Pulmonology — Spoken Teaching Script

A complete walk-through of the Inner Circle Pulmonary compilation

Narrated end to end — physiology through pulmonary surgery

Pulmonary Physiology

Alright, let's start at the very beginning, because everything in pulmonology rests on a small set of physiology ideas. If you really own these, the clinical chapters basically explain themselves. So settle in, and let's build this from the ground up.

The Lay of the Land: Lung Topography

First, a quick orientation to where the lungs and pleura actually sit, because this shows up in exam questions about where to listen, where to tap, and where a needle is safe. Think of two surfaces: the visceral pleura that hugs the lung itself, and the parietal pleura that lines the chest wall. The lung and its visceral pleura sit a little higher; the parietal pleura dips a little lower, and that gap between them is the costodiaphragmatic recess, the safe pocket of pleural space.

Here is the clean way to remember the lower borders. Follow three vertical lines down the chest. At the midclavicular line, the lung reaches the sixth rib and the parietal pleura the eighth rib.

At the midaxillary line, the lung reaches the eighth rib and the parietal pleura the tenth. And posteriorly, at the paravertebral line, the lung reaches the tenth rib and the parietal pleura the twelfth. So the pattern is six, eight, ten for the lung, and eight, ten, twelve for the parietal pleura, each two ribs lower.

That two-rib gap is exactly the recess where fluid collects and where you can safely place a needle below the lung but still inside the pleural space.

The Cells of the Lung and What Goes Wrong With Each

Now let's meet the cells lining the lung, because the diseases are really just specific cells failing at their specific jobs. This is a beautiful structure-meets-disease table, so let's walk it cell by cell.

Start with the alveolar macrophage. Its job is housekeeping: it clears alveolar debris, old surfactant, pathogens, inhaled particles. When the macrophage cannot clear surfactant, surfactant piles up in the alveoli, and that is pulmonary alveolar proteinosis. So P.A.P equals a macrophage clearance problem.

Next, the type one pneumocyte. This is the thin, flat cell that forms the lining where gas exchange actually happens. It is delicate, and when you inhale something injurious, it is the cell that gets damaged first, which is how inhalational injury leads to A.R.D.S. Type one equals the gas-exchange surface, and it is fragile.

Then the type two pneumocyte, which has two famous jobs: it makes surfactant, and it is the stem cell reservoir that regenerates type one cells after injury. So when a premature baby has too few type two cells, there is not enough surfactant, the alveoli collapse, and you get hyaline membrane disease, which is neonatal respiratory distress syndrome. Type two equals surfactant plus repair.

The ciliated airway epithelial cell runs the mucociliary escalator, sweeping mucus and trapped junk up and out, and it handles salt and water balance at the airway surface. When the cilia do not beat properly, that is primary ciliary dyskinesia, also called Kartagener syndrome. And in cystic fibrosis, the airway surface liquid dries out, the mucus gets thick, and clearance fails. So this cell connects to both ciliary dyskinesia and C.F.

The club cell, sometimes still called the Clara cell, protects and repairs the distal airway and helps detoxify inhaled substances, including tobacco smoke. That detox role is why it ties into C.O.P.D from smoking.

The goblet cell secretes mucins. In C.O.P.D and asthma you get goblet cell metaplasia and mucus hypersecretion, which is exactly the airway clogging you see clinically.

And finally the fibroblast, which maintains the interstitial scaffolding of the lung. Too much fibroblast activity gives you idiopathic pulmonary fibrosis, where the interstitium scars; too little fibroblast activity contributes to emphysema, where the scaffolding breaks down. So the fibroblast sits on a dial: crank it up, you fibrose; let it fall, you get emphysema.

Ventilation and Perfusion: The V/Q Spectrum

Okay, so here is one of the highest-yield ideas in all of pulmonary: the relationship between ventilation, which we call V, the air getting to alveoli, and perfusion, which we call Q, the blood flowing past those alveoli. Healthy lungs match the two. Disease pushes you off that match in one of two directions, and I want you to picture this as a sliding spectrum.

On one extreme, you have perfusion with no ventilation. Blood flows past alveoli that are not getting any air, so V is zero. That is an intrapulmonary shunt. Blood goes in deoxygenated and comes out still deoxygenated. Classic causes are things that flood or collapse the alveoli: diffuse pulmonary edema, A.R.D.S, lobar pneumonia, and localized atelectasis.

The hallmark of a true shunt is that giving extra oxygen does not fix the hypoxemia, because the oxygen never reaches the blood. Hold onto that idea; it explains why a patient with dense pneumonia or A.R.D.S stays hypoxic despite high-flow oxygen.

In the middle is the normal lung, V and Q nicely matched.

On the other extreme, you have ventilation with no perfusion, so Q is zero. Air reaches alveoli that have no blood flow. That is dead-space ventilation. The textbook cause is pulmonary embolism, where a clot blocks the blood supply to a ventilated region. massive P.E, a big right-to-left shunt, or severe pulmonary hypertension pushes you to the far dead-space end.

So the whole spectrum runs from shunt, V/Q of zero, through normal, V/Q of one, out to dead space, V/Q approaching infinity. Pneumonia and edema and atelectasis live on the shunt side; P.E lives on the dead-space side. That single picture organizes a huge amount of this subject.

Running a Ventilator: The Core Goals

Let's talk ventilators, and I want to keep this very practical. When a patient is on a ventilator, the oxygen goals are deliberately modest: keep the oxygen saturation between about eighty-eight and ninety-five percent, and the arterial oxygen, the P.a.O.2, between roughly fifty-five and eighty millimeters of mercury. We are not chasing a hundred percent, and there is a reason.

That reason is oxygen toxicity. Prolonged high inspired oxygen, a F.i.O.2 above sixty percent, damages the lung. So if a patient needs better oxygenation, you would rather raise the peep than just crank up the F.i.O.2, because higher peep lets you achieve good oxygen levels at a lower, safer F.i.O.2.

Here is the single cleanest mental model for ventilator adjustments, and it is worth memorizing word for word. Oxygen is changed by altering F.i.O.2 or peep. Carbon dioxide is changed by altering tidal volume or respiratory rate, with respiratory rate generally preferred. So oxygen, think F.i.O.2 and peep; C-O-two, think rate and tidal volume. If a question asks how to fix oxygenation versus how to fix C-O-two, that one sentence is your answer.

And tidal volumes in a mechanically ventilated patient should be about six to eight milliliters per kilogram of ideal body weight. So a seventy-kilogram patient gets a tidal volume around four hundred twenty milliliters. Small, lung-protective breaths.

peep: What It Does and Why We Love It

peep stands for positive end-expiratory pressure, and it is the setting that keeps a little positive pressure in the lung, around five centimeters of water, through the entire breathing cycle, both inhalation and exhalation. The whole point is to prevent alveolar collapse.

Mechanistically, peep raises alveolar pressure and alveolar volume, which reopens collapsed or unstable alveoli and improves the ventilation-perfusion relationship. By recruiting those alveoli, it lets you maintain an adequate PaO _2 at a low, safe oxygen concentration, under sixty percent, so it directly reduces oxygen toxicity risk.

The advantages list is a tidy set: peep avoids atelectasis, increases oxygenation, increases the gas-exchange surface area, increases functional residual capacity, and increases pulmonary compliance. If you remember that peep keeps alveoli open, every one of those advantages follows logically.

But peep is positive pressure pushed into the chest, and that has complications. Barotrauma is the big idea, and the clinical tell is worsening shortness of breath after peep was increased. The dangerous version is a pneumothorax, and you suspect that if the patient suddenly becomes hypotensive with mediastinal shift or tracheal deviation.

You diagnose it with a chest x-ray, and the immediate treatment is needle decompression. Pneumothorax here is often secondary to the barotrauma itself.

Noninvasive Positive Pressure Ventilation

Now noninvasive positive pressure ventilation, the mask-based support like B.i.P.A.P. The strongest evidence for using it is in severe C.O.P.D exacerbations, where it can prevent intubation and prevent extubation failure; in cardiogenic pulmonary edema; and in acute respiratory failure, including postoperative hypoxemic failure and immunosuppressed patients, and to facilitate early extubation.

But there is a clear list of contraindications, and they cluster into three buckets. Medical instability: cardiac or respiratory arrest or impending arrest, severe acidosis with a pH under seven point one, A.R.D.S, and nonrespiratory organ failure like unstable arrhythmia, hemodynamic instability, encephalopathy with a Glasgow Coma Score under ten, or a G.I bleed. Inability to protect the airway: an uncooperative or agitated patient, or one who cannot clear secretions and has a high aspiration risk. And mechanical issues: recent esophageal anastomosis, facial or neurologic surgery, deformity or trauma, and upper airway obstruction.

And the punchline tying it together: a somnolent or comatose patient cannot protect their airway, and that means intubation, not a mask.

Positive Pressure and the Heart

Here is a subtle but heavily tested interaction. Positive pressure mechanical ventilation causes an acute increase in intrathoracic pressure. Normally fine. But in a patient with already low central venous pressure, for example hypovolemic shock, that rise in intrathoracic pressure can squeeze off venous return, cause an acute loss of right ventricular preload, and trigger sudden cardiac death.

So in a hypovolemic patient, slapping on positive pressure can crash them. Fill the tank first.

Now the flip side, which is genuinely elegant: positive pressure ventilation in cardiogenic pulmonary edema actually helps, and there is a whole cascade behind that mortality benefit. Raising intrathoracic pressure reduces right ventricular preload and increases right ventricular afterload, both of which lower left ventricular preload. It also lowers the mean arterial pressure a touch and reduces the left ventricular transmural pressure gradient, which lowers left ventricular afterload. Lower afterload means improved L.V performance, better stroke volume and diastolic filling, which raises cardiac output.

Meanwhile the positive pressure pushes interstitial lung water back, improving oxygenation by reducing intrapulmonary shunting. The net result is improved L.V performance, increased cardiac output, pulmonary decongestion, and better end-organ oxygen delivery and survival. So in a flashing-pulmonary-edema patient, that mask is doing real lifesaving work.

One more practical pearl: continuous positive airway pressure, C.P.A.P, dries out the nasal mucosa and predisposes to recurrent epistaxis, recurrent nosebleeds. Humidification often prevents C.P.A.P-associated epistaxis. Small detail, easy point.

The Endotracheal Tube and Extubation

When you advance an endotracheal tube too far, it preferentially slides into the right mainstem bronchus, because the right main bronchus is more vertical. The clinical clue is asymmetric chest expansion with markedly decreased breath sounds on the left side, because you are only ventilating the right lung. The ideal tube tip sits about two to six centimeters above the carina.

Now, weaning. The initial criteria for extubation readiness are a pH above seven point two five; adequate oxygenation, meaning a PaO _2 at or above sixty on minimal support, with FiO _2 at or under forty percent and peep at or under five; and intact inspiratory effort with enough mental alertness to protect the airway.

Because there is still a short-term risk of needing reintubation, patients who meet those criteria should undergo a spontaneous breathing trial. During the trial, the patient stays intubated but ventilatory support is turned off, so you see how they do on their own. You can sharpen the prediction with the rapid shallow breathing index, the R.S.B.I, which is respiratory rate per minute divided by tidal volume in liters. A high R.S.B.I, say above one hundred five, means the patient is breathing fast and shallow and is unlikely to do well without continued support. Fast and shallow is bad.

Two related pearls. Because a tube can damage the larynx and upper trachea over time, causing tracheal stenosis, a tracheostomy is indicated when prolonged intubation, roughly more than seven to ten days, is required. And mechanical ventilation itself causes respiratory muscle atrophy and insufficiency, so physiotherapy, coughing, repositioning to sitting, and moving the patient all help restore respiratory strength afterward.

Pulmonary Function Tests

Let's read pulmonary function tests, because a clean grasp here distinguishes asthma, C.O.P.D, restriction, and pulmonary vascular disease in a single question. Think in three numbers: total lung capacity, the F.E.V.1-to-F.V.C ratio, and the D.L.C.O, the diffusing capacity.

In asthma, total lung capacity is normal or increased from air trapping, the F.E.V.1-to-F.V.C ratio is decreased but reverses with a bronchodilator, and D.L.C.O is normal or even slightly increased. In C.O.P.D, total lung capacity is increased, the ratio is decreased, and D.L.C.O is decreased, though it can be normal in early C.O.P.D. In interstitial lung disease, total lung capacity is decreased, the ratio is actually normal, and D.L.C.O is decreased. In pulmonary arterial hypertension, lung capacities and the ratio are normal but D.L.C.O is decreased, because the problem is the vasculature, not the airways. And in restrictive chest wall disease, total lung capacity is decreased, the ratio normal, and D.L.C.O normal, because the lung tissue itself is fine; it is just the bellows that are limited.

The decoder ring: a low ratio means obstruction, a low total lung capacity means restriction, and D.L.C.O tells you whether the gas-exchange membrane or vasculature is involved. Restrictive chest wall disease keeps a normal D.L.C.O because the lung parenchyma is healthy; I.L.D and P.A.H drop the D.L.C.O because the membrane or vessels are diseased.

Auscultation: Reading the Chest Exam

Now the bedside exam, and this table is pure exam gold because the physical findings let you call the diagnosis before any imaging. For each condition, track four things: breath sounds, tactile fremitus, percussion note, and whether the mediastinum shifts.

Normal lung: bronchovesicular and vesicular breath sounds, normal Fremitus, resonant percussion, no shift. Consolidation, like lobar pneumonia: increased breath sounds with crackles and egophony, increased Fremitus, dull percussion, no shift. The key is that solid lung transmits sound better, so Fremitus goes up and you hear egophony.

Pleural effusion: decreased or absent breath sounds, decreased Fremitus, dull percussion, and if large, the mediastinum shifts away from the effusion. Pneumothorax: decreased or absent breath sounds, decreased Fremitus, but hyperresonant percussion, because now there is air, not fluid, and if it is a tension pneumothorax the mediastinum shifts away. Emphysema: decreased breath sounds, decreased Fremitus, hyperresonant percussion, no shift. And atelectasis from something like mucus plugging: decreased or absent breath sounds, decreased Fremitus, dull percussion, and the mediastinum shifts toward the collapse if it is large.

So the two big discriminators are percussion and shift direction. Dull plus shift away equals effusion. Hyperresonant plus shift away equals tension pneumothorax.

Dull plus shift toward equals atelectasis. Increased fremitus and egophony equals consolidation.

Diagnostic Pulmonary Tests

Quick tour of the test menu and what each is good and bad at. Spirometry is the gold standard for evaluating pulmonary function, things like F.V.C and F.E.V.1, but it is hard to perform in an unstable patient. A peak flow meter assesses airflow out of the lungs, the peak expiratory flow rate, but is less accurate than spirometry. Chest x-ray is first-line imaging for tracheal position, lung fields, bones, and heart size with low radiation, but it is insensitive for small tumors and for P.E and gives no information about lung function.

Chest C.T gives rapid detailed visualization but at significant radiation exposure and, again, no functional information. Pulse oximetry rapidly assesses oxygenation at the fingertip, earlobe, or an infant's foot, but is inaccurate if the extremity is cold, callused, or moving, and it cannot assess ventilation. And arterial blood gas quantitatively measures pH, oxygen, carbon dioxide, bicarbonate, and base deficit, with a small risk of bleeding, infection, and radial artery thrombosis.

And here is a clinical pearl that bridges to neuromuscular disease: F.V.C is the gold standard for assessing ventilation, and a decline in F.V.C, especially below twenty milliliters per kilogram, signals impending respiratory failure. So in something like Guillain-Barré, you watch the F.V.C.

Capnography: Reading the C-O-two Waveform

Capnography is the continuous C-O-two waveform, and it is incredibly useful, so let's learn to read it. A normal capnogram has a characteristic rectangular waveform with four phases. The crucial concept is the flat waveform: if the trace goes flat, the sensor, which sits at the hub of the endotracheal tube, is not detecting any C-O-two at all.

That flat line means one of two things. Either the tube is in the esophagus, because no C-O _2 is produced in the stomach or esophagus, so an esophageal intubation reads as a flat line. This is a real risk with an uncuffed tube that gets displaced during transport, sliding the short distance from trachea to esophagus. As an aside, uncuffed tubes are common in children because they are thought to cause less mucosal injury. The other cause of a flat line is prolonged cardiac arrest, where C-O _2 production has essentially ceased.

There are recognizable abnormal patterns: hyperventilation shows increased respiration with decreased end-tidal C-O _2 ; hypoventilation shows decreased respiration with increased end-tidal C-O _2 ; bronchospasm shows loss of the sharp angle between phases two and three, giving a shark-fin shape with a rising baseline; tube displacement shows a sudden loss across all phases or a reduction in end-tidal C-O _2 ; C.P.R shows a low end- tidal C-O-two from low cardiac output and poor perfusion; and apnea shows absence of phases zero, one, two, and three, a flat trace.

The single most testable takeaway: capnography is the most reliable method for verifying that an endotracheal tube is in the trachea and not the esophagus. So if a question asks how to confirm tube placement, the best answer is capnography.

Peak Airway Pressure Versus Plateau Pressure

Now a concept that trips people up but is actually simple once you see the picture: peak airway pressure versus plateau pressure. The peak airway pressure is the maximum pressure measured while the tidal volume is being delivered, and it equals the sum of two things: the resistive pressure, which is flow times resistance, plus the plateau pressure. Write that down: peak equals resistive plus plateau.

The plateau pressure is measured during an inspiratory hold maneuver, when airflow, and therefore resistive pressure, are both zero. So plateau pressure reflects the compliance of the lung. If compliance is the problem, the plateau pressure rises. Increased plateau pressure equals decreased compliance, because elastic pressure is inversely related to compliance. And plateau pressure itself equals elastic pressure plus peep.

Here is how this becomes a diagnostic engine when peak pressure is high. Ask: is the plateau normal or also high? If the peak pressure is up but the plateau is normal, the problem is airway resistance, and the causes are bronchospasm, a mucus plug, or the patient biting the endotracheal tube. If both peak and plateau are up, the problem is compliance, and the causes are pneumothorax, pulmonary edema, pneumonia, atelectasis, or right mainstem intubation.

So high peak with normal plateau equals a resistance problem; high peak with high plateau equals a compliance problem. That forks worth a lot of points.

One last ventilator pearl: the alveolar end-expiratory pressure is normally equal to atmospheric pressure. But in obstructive lung disease the alveoli cannot empty completely, leaving a higher-than-normal end-expiratory pressure, called intrinsic peep or auto-peep, which you measure with an end-expiration hold maneuver.

D.L.C.O and the Differential Diagnosis

Let's use the diffusing capacity, D.L.C.O, as a sorting tool, combined with the spirometry pattern. Picture a grid: obstructive pattern versus restrictive pattern versus normal spirometry, crossed with low, normal, or increased D.L.C.O.

Low D.L.C.O with obstruction points to emphysema. Low D.L.C.O with a restrictive pattern points to interstitial lung disease, sarcoidosis, asbestosis, or heart failure. Low D.L.C.O with normal spirometry points to anemia, pulmonary embolism, or pulmonary hypertension, the vascular and blood causes. Normal D.L.C.O with obstruction points to chronic bronchitis or asthma. Normal D.L.C.O with restriction points to musculoskeletal deformity or neuromuscular disease, again because the parenchyma is fine. And increased D.L.C.O shows up in asthma, in morbid obesity, and most importantly in pulmonary hemorrhage and polycythemia, because extra blood in the alveoli or extra red cells soak up more of the test gas.

Hypoxemia: The Six Causes and the Two Questions

This is one of the absolute cornerstones, so let's nail it. There are six causes of hypoxemia, and you separate them with two questions: is the A-a gradient normal or increased, and does the hypoxemia correct with supplemental oxygen?

Reduced inspired oxygen, like high altitude: normal A-a gradient, and yes, it corrects with oxygen. Hypoventilation, like C.N.S depression or neuromuscular weakness: normal A-a gradient, corrects with oxygen. Dead-space ventilation, V/Q approaching infinity, the classic being pulmonary embolism: increased A-a gradient, corrects with oxygen.

Diffusion limitation, like emphysema or I.L.D: increased A-a gradient, corrects with oxygen. Intrapulmonary shunt, V/Q of zero, from pneumonia, pulmonary edema, or atelectasis: increased A-a gradient, and crucially does not correct with oxygen. And intracardiac shunt, right to left, like tetralogy of Fallot or Eisenmenger: increased A-a gradient, and does not correct with oxygen.

So organize it like this. The two causes with a normal A-a gradient are reduced inspired oxygen and hypoventilation. Everything else widens the gradient.

And the two that do not correct with oxygen are the shunts, intrapulmonary and intracardiac, because in a true shunt the oxygen never reaches the blood. If oxygen fixes it, it is not a shunt. That logic answers a remarkable number of questions.

Methemoglobinemia

Now a few specific oxygen-carrying disasters, starting with methemoglobinemia. The history is exposure to an oxidizing substance, classically dapsone, nitrites, or a local or topical anesthetic. On exam you see cyanosis, a pulse oximetry saturation stuck around eighty-five percent, and dark chocolate-colored blood. In the lab there is a saturation gap, a greater-than-five-percent difference between the oxygen saturation on pulse oximetry and on arterial blood gas, with a normal P.a.O.2.

Here is the why. Standard pulse oximetry cannot detect methemoglobin, so it reads a falsely low saturation. Co-oximetry, on the other hand, can detect hemoglobin, methemoglobin, and carboxyhemoglobin. And arterial blood gas measures free, unbound oxygen, which is not affected by methemoglobin, so the P.a.O.2 looks normal even while the patient is cyanotic. That mismatch, normal P.a.O.2 with low pulse-ox saturation and chocolate blood, is the giveaway.

Cyanide Toxicity

Cyanide toxicity. Common sources are structure fires from combustion of plastics, occupational exposure like mining, and cyanide-containing medications, classically sodium nitroprusside. Mechanistically, cyanide inhibits oxidative phosphorylation and forces anaerobic metabolism, and it is rapidly lethal if untreated.

Clinically you get hypertension, tachycardia, and tachypnea progressing to circulatory collapse and death; headache, confusion, and anxiety progressing to seizures and coma; cherry-red skin; and an elevated anion gap metabolic acidosis with a rising lactic acid, because cells are stuck in anaerobic metabolism. Management is decontamination plus supportive care, a hundred percent oxygen, I.V fluids, and vasopressors, with empiric treatment using hydroxocobalamin, plus or minus sodium thiosulfate.

A safety point on the antidote choice: sodium nitrite plus sodium thiosulfate is an alternate regimen, but sodium nitrite is contraindicated in carbon monoxide poisoning, because it induces methemoglobinemia and you do not want to further cripple oxygen carrying in a C-O victim. For decontamination specifically: dermal exposure, remove clothing and decontaminate skin; ingestion, activated charcoal; for all exposures, give the antidote, hydroxocobalamin preferred, sodium thiosulfate as alternate, and if no antidote is available, nitrites to induce methemoglobinemia. Respiratory support means no mouth-to-mouth, supplemental oxygen, and airway protection. Cardiovascular support means I.V fluids for hypotension.

Two pearls. Nitroprusside-related cyanide toxicity risk rises with prolonged infusion over twenty-four hours, high infusion rates of five to ten micrograms per kilogram per minute, and chronic kidney disease. And to prevent cardiorespiratory arrest and permanent neurologic disability, smoke inhalation victims should be treated empirically for cyanide toxicity. Do not wait for confirmation.

Carbon Monoxide Poisoning

Carbon monoxide poisoning. Epidemiology: smoke inhalation, defective heating systems, and gas motors running in poorly ventilated areas. Manifestations split by severity. Mild to moderate gives headache, confusion, malaise, dizziness, and nausea.

Severe gives seizure, syncope, coma, myocardial ischemia, and arrhythmias. Diagnosis is the carboxyhemoglobin level on arterial blood gas, plus an E.C.G and cardiac enzymes if needed. On brain M.R.I, you may see bilateral, symmetric hyperintensity in the globus pallidus, that is the classic image. Treatment is high-flow hundred percent oxygen, with intubation and hyperbaric oxygen for severe cases.

Confirm the diagnosis by measuring carboxyhemoglobin: above three percent in nonsmokers, above ten percent in smokers. And just like with methemoglobin, standard pulse oximetry is unreliable here and can read normal, because it cannot differentiate carboxyhemoglobin from oxyhemoglobin.

Picture the classic vignette: a young person with two months of headache and a recent decline in school performance who lives in the basement of the house, with a hemoglobin of nineteen point six. The diagnosis is cerebral hypoxia from carbon monoxide. C-O binds hemoglobin about two hundred forty times more strongly than oxygen and blocks normal oxygen delivery to cells, creating a chronic hypoxic state that stimulates erythropoietin production, which is why the hemoglobin is high. And C-O poisoning can induce myocardial infarction, presenting with chest pain, E.C.G changes, elevated troponin, and bilateral radiographic infiltrates, but with no acute coronary occlusion on catheterization.

Inhalation Injury

Inhalation injury, which ties the fire-related topics together. The pathophysiology is upper airway thermal injury, plus or minus lower airway chemical injury, often with concomitant C-O and cyanide poisoning. Concerning features in the history are smoke exposure in an enclosed space, and on exam, singed hair, facial burns, carbonaceous sputum, and wheezing.

Now separate concerning features from strong indicators of actual airway injury, because they drive different actions. Strong indicators are oropharyngeal blistering or edema, retractions, respiratory distress, and hypoxia. For management, give a hundred percent oxygen to displace C-O. A stable patient with concerning features but no strong indicators gets bedside fiberoptic laryngoscopy to look. But an unstable patient, or one with strong indicators of airway injury, goes straight to endotracheal intubation, because that airway is about to close.

Hemoptysis

Let's finish physiology with hemoptysis, coughing up blood. Group the causes by system. Pulmonary causes: bronchitis, lung cancer, bronchiectasis. Cardiac: mitral stenosis and acute pulmonary edema. Infectious: tuberculosis, lung abscess, bacterial pneumonia, aspergillosis.

Hematologic: coagulopathy. Vascular: pulmonary embolism, arteriovenous malformation. Systemic disease: granulomatosis with polyangiitis and Goodpasture syndrome, the pulmonary-renal syndromes. And other: trauma and inhaled cocaine use.

For massive hemoptysis, the sequence of management is the part to memorize. First, position the patient in the dependent, lateral position, lying on the side that is bleeding, so blood does not spill over and drown the airways of the opposite, good lung. Second, secure the airway. Third, stabilize. Fourth, stop the bleeding with bronchoscopy or embolization. The threshold for calling it massive is more than six hundred milliliters in twenty-four hours, or more than one hundred milliliters per hour.

Walk the workup. After history and physical to rule out other sources, like oropharyngeal or gastrointestinal bleeding, split by severity. Mild to moderate gets chest x-ray, C.B.C, coagulation studies, renal function, urinalysis, and a rheumatologic workup if suspected, then a C.T scan plus or minus bronchoscopy depending on imaging and whether intervention is needed, then treat the cause. Massive bleeding goes to secure airway, breathing, and circulation; if bleeding stops, proceed with the standard workup; if bleeding continues, treat with bronchoscopic interventions, embolization, or resection.

Head, Neck, and Nose

Okay, so now we move up to the head, neck, and nose. A lot of this is pediatric airway, and the unifying theme is: where is the noise coming from, and is the airway about to close? Let's work through it.

One quick anchor before stridor: adenoid hypertrophy, hyperplasia of the pharyngeal tonsils, is the most common cause of nasal obstruction in children. Keep that in your back pocket for the snoring, mouth-breathing kid.

Stridor: Acute Versus Chronic

Stridor is that high-pitched noise of turbulent airflow through a narrowed upper airway, and the smart move is to split causes into acute and chronic.

On the acute side, croup is the big one: parainfluenza virus, most cases in fall and winter, with inspiratory or biphasic stridor, a barky cough, and infectious symptoms. The other acute cause is foreign body aspiration, with a possible choking episode, inspiratory stridor or wheeze, and focally diminished breath sounds.

On the chronic side, laryngomalacia is the classic: a floppy supraglottis, prominent around age four to eight months, with inspiratory stridor that worsens when the baby is feeding, crying, or supine, and improves when prone. Then a vascular ring, where the great vessels encircle and compress the trachea, giving biphasic stridor that improves with neck extension. And an airway hemangioma, where hemangiomas enlarge in the first few weeks of life, causing worsening biphasic stridor, often with concurrent skin hemangiomas in a beard distribution.

Tracheal Stenosis, Tracheomalacia, and Tracheal Collapse

Tracheal stenosis, meaning rigid narrowing, and tracheomalacia, meaning weakness and collapsibility, are both complications of prolonged endotracheal intubation, and they cause dyspnea and noisy breathing. Tracheal stenosis is associated with prolonged mechanical ventilation over about two weeks, and it presents with slowly progressive, rather than episodic, dyspnea, potentially with expiratory stridor.

There is a lovely physiology vignette here: an adolescent boy with vackterl presenting with subacute cough, expiratory stridor, a forced vital capacity that is less than the slow vital capacity, and a scooped-out flow-volume loop, all of which point to tracheal collapse. The key idea is that the forced vital capacity, the air you can forcefully expire, is almost always about equal to the slow vital capacity, the air expired in a passive breath. The one exception is tracheal collapse, because forceful expiration actually causes obstruction, so less air comes out forcefully. That F.V.C-less-than-SVC clue is the fingerprint of tracheal collapse.

Vocal Cord Dysfunction

Vocal cord dysfunction is paradoxical closure of the cords during inspiration, presenting with intermittent dyspnea and noisy breathing, specifically inspiratory stridor, triggered by exercise or psychosocial stress, and it is more common in young women. You diagnose it with laryngoscopy showing vocal cord adduction during inspiration. For acute episodes, have the patient sniff or pant, which activates the posterior cricoarytenoid to abduct the cords, and you can use noninvasive positive-pressure ventilation.

Endotracheal intubation should ideally be avoided. Long-term treatment is mainly education and therapy with a speech-language pathologist. The reason this matters is that vocal cord dysfunction masquerades as refractory asthma, but it does not respond to asthma meds.

And while we are here: velopharyngeal insufficiency is a common sequela of cleft palate, with or without surgical repair. It is the inability to properly close the velopharyngeal port that separates the nasopharynx from the oropharynx during speech, often from a shortened palate or persistent palatal defect, and it produces high-pitched, hypernasal, or whistling speech with reduced intelligibility.

Laryngomalacia, In Detail

Back to laryngomalacia for the full picture. The pathophysiology is collapse of the supraglottic tissues on inspiration, likely from laryngeal hypotonia, possibly delayed maturation. Clinically, inspiratory stridor that worsens when supine, peaking at age four to eight months.

Diagnosis is laryngoscopy, classically showing an omega-shaped epiglottis. Management for most cases is reassurance with close follow-up, plus or minus treating concurrent gastroesophageal reflux, and supraglottoplasty is reserved for severe symptoms. The reassuring fact is that it presents in infancy and typically resolves by about eighteen months. And the imaging study to confirm it is fiberoptic laryngoscopy.

Torus Palatinus

Torus palatinus is the answer to a hard, immobile mass on the hard palate of a young individual. It is a benign bony growth. It can increase in size throughout life, and no medical or surgical therapy is required unless it becomes symptomatic. It can be congenital or develop later in life. So when you see a bony bump in the midline of the hard palate, relax: it is benign.

Upper Respiratory Infections: Telling Them Apart

Let's distinguish the common upper respiratory illnesses, because the exam loves to make you choose between viral syndrome, influenza, and streptococcal pharyngitis. Onset: viral is slow, stepwise, migratory, or evolving; influenza is abrupt and often dramatic; strep is variable. Upper respiratory symptoms: prominent rhinorrhea, coryza, sneezing, and mild pharyngitis in viral; usually mild in influenza; predominantly pharyngeal symptoms in strep. Systemic symptoms: usually mild in viral; prominent in influenza with possible high fever, myalgias, and headache; variable in strep with possible fever and myalgias. Exam: viral shows nasal edema with a normal or slightly erythematous pharynx; influenza is variable but often unremarkable; strep shows pharyngeal erythema, tonsillar hypertrophy and exudates, and tender cervical lymph nodes.

In children specifically, learn the key respiratory infections with their classic pathogens. Nasopharyngitis, the common cold: rhinovirus, influenza, coronavirus, with congestion, discharge, sneezing, cough, sore throat. Laryngotracheitis, croup: parainfluenza virus, age six months to three years, with a barky cough, stridor, and hoarseness.

Diphtheria: Corynebacterium diphtheriae, with sore throat, cervical lymphadenopathy, and a coalescing pseudomembrane. Epiglottitis: Haemophilus influenzae, in unvaccinated children, with sore throat, dysphagia, drooling, tripod position, and respiratory distress. And bronchiolitis: respiratory syncytial virus, age under two, with wheezing and coughing.

Pharyngitis and the Centor Criteria

Pharyngitis evaluation differs between children and adults, so let's get both flowcharts straight. In children: if viral symptoms are present, like cough, conjunctivitis, or oral ulcers, you lean viral and give supportive care; if not, do rapid streptococcal antigen testing. A positive rapid test means streptococcal pharyngitis, treated with oral penicillin or amoxicillin. A negative rapid test must be confirmed with a throat culture, because in kids the risk of rheumatic fever is high enough that you do not want to miss it.

For the Centor criteria, count four features: fever by history, tender anterior cervical lymphadenopathy, tonsillar exudates, and absence of cough. Zero to one present: no testing or treatment for strep. Two to three present: rapid streptococcal antigen test. Four present: rapid test, or empic penicillin or amoxicillin. Treat positives with penicillin or amoxicillin. If the patient has a penicillin allergy, use a macrolide or clindamycin.

The ten-day course of penicillin for strep pharyngitis is worth it because it decreases symptom severity and duration, prevents spread to close contacts, and prevents acute rheumatic fever. And the single highest-yield distinction: in a child with fever, tonsillar exudates, and tender anterior cervical lymphadenopathy, the next step is rapid streptococcal antigen testing, because G.A.S pharyngitis in children should always be confirmed by rapid test or culture before starting antibiotics, whereas adults who meet all the Centor criteria can be treated empirically.

Epiglottitis

Epiglottitis is an airway emergency, so let's be precise. Epidemiology: Streptococcus pneumoniae and Haemophilus influenzae, with risk reduced by the H. influenzae vaccine. Clinically it is rapidly progressive and life-threatening, with fever, sore throat, drooling, and a muffled voice, airway obstruction with stridor and dyspnea, pooled oropharyngeal secretions, and laryngotracheal tenderness. Diagnosis is direct visualization and imaging, the lateral neck x-ray showing the thumbprint sign of an enlarged epiglottis; in adults you may just see a thickened epiglottis. Treatment is establishing an early artificial airway if needed, plus intravenous antibiotics, ceftriaxone plus vancomycin.

A clean discriminator: the presence of drooling helps differentiate epiglottitis from croup, which is laryngotracheobronchitis. And for airway management, patients with epiglottitis who develop rapid-onset respiratory failure, with tripod positioning, hypoxia, drooling, and tachypnea, require urgent airway management. That means bag-valve-mask ventilation with a hundred percent oxygen, followed by endotracheal intubation with advanced equipment like a video laryngoscope. A single failed attempt at video-assisted intubation should prompt surgical cricothyrotomy, which bypasses the epiglottic swelling and obstruction.

Retropharyngeal Abscess

Retropharyngeal abscess. Epidemiology: age two to four, but it can occur at any age, and it is polymicrobial, group A Streptococcus, Staphylococcus aureus, and respiratory anaerobes. Symptoms: fever, odynophagia or dysphagia, neck pain, drooling, a muffled hot-potato voice, and trismus. On exam, a retropharyngeal bulge and limited neck extension.

Diagnosis: a lateral neck x-ray showing increased prevertebral thickening, and C.T of the neck with contrast. Management: airway protection, intravenous antibiotics like ampicillin-sulbactam or clindamycin, plus or minus surgical drainage.

Clinically it often presents with neck pain, odynophagia, and fever following penetrating trauma to the posterior pharynx, such as a fish bone, and may also have much rigidity and bulging of the pharyngeal wall. So the classic vignette is a child who cannot extend the neck, has a widened prevertebral space on x-ray, after a week of fever and sore throat; that is a retropharyngeal abscess, often a complication of a viral upper respiratory infection. The x-ray shows widening of the prevertebral space and sometimes soft tissue emphysema. The key differential is peritonsillar abscess.

And here is the scary complication to know: the life-threatening result of contiguous spread from a retropharyngeal abscess is acute necrotizing mediastinitis. The deep neck spaces are highways to the chest. The retropharyngeal space drains to the superior mediastinum; the danger space drains to the posterior mediastinum, the potential space between pericardium and vertebral column; and the prevertebral space extends all the way to the coccyx. So infection in the neck can track straight into the mediastinum.

Peritonsillar Abscess

Peritonsillar abscess. Clinical features: fever, sore throat with difficulty swallowing, trismus, a muffled hot-potato voice, uvula deviation away from the enlarged tonsil, and pooling of saliva. The recommended treatment is incision and drainage plus intravenous antibiotics, but make sure the airway is not compromised first.

Let's walk the management flowchart. Clinical features are severe sore throat, fever, hot-potato voice, and dysphagia. First, check for impending airway obstruction, tripod position, inability to lie flat, severe respiratory distress with nasal flaring, noisy breathing, or retractions. If yes, secure the airway with E.N.T and anesthesia, drain in the operating room, then antibiotics.

If no, check for signs of deep neck space infection, neck pain or stiffness on extension, neck tenderness or swelling, bulging posterior pharyngeal mucosa, or chest pain; if yes, get a C.T of the neck with contrast. If no deep neck signs, look for the clinical diagnosis of peritonsillar abscess, at least one of trismus, unilateral swelling, uvular deviation, or fluctuant bulging of the soft palate; if yes, do needle aspiration or incision and drainage, then antibiotics; if no, it is likely infectious pharyngitis.

Two pearls: trismus is the differentiating feature between peritonsillar abscess and simple tonsillitis. And the differential for a hot-potato voice is the trio of epiglottitis, retropharyngeal abscess, and peritonsillar abscess.

Sinusitis

Acute bacterial rhinosinusitis. The two most common organisms are nontypeable Haemophilus influenzae and Streptococcus pneumoniae, with Moraxella catarrhalis third, about ten percent of cases. Two special associations: Pseudomonas in cystic fibrosis patients, and Staphylococcus aureus in chronic sinusitis, meaning sinus inflammation for more than twelve weeks.

In children, acute rhinosinusitis presents with nasal congestion or purulent drainage and facial pressure or pain, plus or minus fever, cough, headache, loss of smell, and ear pain. The etiology can be viral, with no fever or early resolution of fever, mild symptoms, improvement and resolution by day five to ten; or bacterial, with fever for at least three days, new or recurrent fever after initial improvement, or persistent symptoms for at least ten days. Treatment is intranasal saline, saline irrigation, and N.S.A.I.D's, with antibiotics only if bacterial.

For the diagnostic criteria of acute bacterial rhinosinusitis, you need any one of the following: persistent symptoms for at least ten days without improvement; severe symptoms with high fever above thirty-nine Celsius, purulent nasal discharge, or facial pain for at least three days; or worsening symptoms after at least five days following an initially improving viral upper respiratory infection, the so-called double-sickening pattern. Symptoms include fever, nasal congestion, purulent nasal discharge, maxillary tooth discomfort, and facial pain or pressure that worsens with bending forward. First-line therapy is amoxicillin-clavulanate; the alternate agent is doxycycline or a fluoroquinolone; supportive care includes analgesics, decongestants, saline irrigation, and topical glucocorticoids.

Not recommended due to resistance: plain amoxicillin, macrolides, trimethoprim-sulfamethoxazole, and second or third-generation cephalosporins. The most common predisposing factor is a viral upper respiratory infection, sometimes allergic rhinitis. And because viral and bacterial sinusitis are hard to distinguish, remember that viral rhinosinusitis generally improves by days seven to ten.

One I.C.U pearl: both endotracheal tubes and nasogastric tubes can cause acute sinusitis in critically ill patients by impairing sinus drainage, with fever, cough, headache, and purulent nasal drainage. Diagnose with a C.T of the sinuses showing opacification, and culture the sinus fluid; manage with antibiotics and removal of the obstruction, although operative sinus drainage may be required.

Tracheitis

Bacterial tracheitis is the answer when croup-like symptoms with fever do not resolve with racemic epinephrine. The organism is Staphylococcus aureus, most commonly following a viral prodrome. It presents around age four, follows a viral prodrome, looks like croup that does not resolve, and the child is toxic, genuinely sick.

Diagnosis is endoscopy, laryngoscopy or bronchoscopy, with tracheal culture. Imaging may show the steeple sign, just like croup, so it is not sensitive or specific, and there is no improvement with racemic epi, which tells you it is not croup. Treatment is maintenance of the airway and I.V antibiotics.

Laryngeal Papillomatosis

Recurrent respiratory papillomatosis comes from vertical transmission of human papillomavirus subtypes six and eleven, and it causes hoarseness due to finger-shaped growths on the true vocal cords. Treatment is surgical debridement. So a hoarse child whose mother had genital warts, with warty growths on the cords, that is H.P.V six and eleven.

Rhinitis

Allergic rhinitis: symptoms are rhinorrhea, nasal congestion, sneezing, nasal itching, cough from postnasal drip, and ocular itching and tearing. On exam, look for allergic shiners, which is infraorbital edema and darkening, the allergic salute with a transverse nasal crease, pale bluish enlarged turbinates, pharyngeal cobblestoning, and allergic facies with a high-arched palate and open-mouth breathing. It can also have thick green nasal discharge. Treatment is allergen avoidance plus intranasal corticosteroids. During peak allergy seasons, patients can even have systemic symptoms like fever, or neuropsychiatric symptoms like fatigue and irritability.

Distinguish nonallergic from allergic rhinitis. Nonallergic: nasal congestion, rhinorrhea, sneezing, postnasal drainage; later age of onset, over twenty; no obvious allergic trigger; perennial symptoms that may worsen with seasonal changes; and erythematous nasal mucosa. Treatment is intranasal antihistamine or glucocorticoids for mild, and combination therapy for moderate to severe. Allergic rhinitis: watery rhinorrhea, sneezing, eye symptoms; earlier age of onset; an identifiable allergen or seasonal pattern; pale bluish mucosa; and association with other allergic disorders like eczema, asthma, and eustachian tube dysfunction.

Treatment is intranasal glucocorticoids and antihistamines. The clean discriminator is that nonallergic rhinitis lacks the sneezing and allergic conjunctivitis, the itchy eyes and injected conjunctivae, that classically accompany allergic rhinitis.

Be careful with decongestants, the sympathomimetics like phenylephrine. Do not use them for more than three days, because they produce rebound congestion, called rhinitis medicamentosa. On exam that shows beefy-red nasal mucosa, as opposed to the edematous, pale mucosa of allergic rhinitis. Treatment is cessation of the medication and nasal glucocorticoids.

Septal Hematoma

A septal hematoma presents after nasal trauma as a fluctuant swelling of the nasal septum. It should be recognized and promptly drained to avoid complications of infection, septal perforation, and nasal deformities, because a hematoma prevents diffusion of nutrients from the perichondrium to the septal cartilage, and the cartilage dies. So if a patient develops a whistling noise during respiration after rhinoplasty, the likely diagnosis is nasal septal perforation, usually resulting from a septal hematoma, which is more common, or a septal abscess, which is less common.

Neck Masses

Pediatric neck masses sort nicely by location: midline, lateral, or posterior. Midline: a thyroglossal duct cyst, which forms a tract between the foramen cecum and the base of the anterior neck, is cystic, moves with swallowing or tongue protrusion, and often presents after an upper respiratory infection; and a dermoid cyst, which has trapped epithelial debris, occurs along embryologic fusion planes, and shows no displacement with tongue protrusion. Lateral: a branchial cleft cyst, whose tract may extend to the tonsillar fossa from the second branchial arch or the pyriform recess from the third, and sits anterior to the sternocleidomastoid muscle; reactive adenopathy, which is firm, often tender, with multiple nodules; and Mycobacterium avium lymphadenitis, with a necrotic lymph node, violaceous skin discoloration, and frequent fistula formation. Posterior: a cystic hygroma, which is dilated lymphatic vessels.

A unifying point: like a thyroglossal duct cyst, which also forms from an incomplete involution of an embryologic remnant, a branchial cleft cyst is often detected when it becomes secondarily infected after an upper respiratory infection, leading to erythema, tenderness, and sometimes drainage of fluid from a sinus tract.

And the full thyroglossal duct cyst picture: embryologically it forms along the path of thyroid descent, from the foramen cecum at the base of the tongue to the base of the anterior neck. Clinically it is a midline cystic neck mass that moves superiorly with swallowing or tongue protrusion, often presents after an upper respiratory infection from secondary infection, and is associated with ectopic thyroid tissue. The crucial management step is to confirm the presence of normal thyroid tissue before removing the cyst, because the cyst could be the patient's only functioning thyroid; then surgical resection of the cyst, its associated tract, and the central portion of the hyoid bone, which is the Sistrunk procedure.

The Mediastinum

Alright, let's step into the chest itself, starting with the mediastinum, the central compartment. The exam basically wants you to localize a mass by compartment, because location tells you the likely diagnosis.

Mediastinal Masses by Compartment

Split the mediastinum into anterior, middle, and posterior. For the anterior mediastinum, remember the four T's: thymoma, thyroid neoplasm, teratoma, and terrible lymphoma. The middle mediastinum holds the bronchogenic cyst, tracheal tumor, pericardial cyst, lymphoma, lymph node enlargement, and an aortic arch aneurysm. And the posterior mediastinum is the home of neurogenic tumors, like neurofibroma and schwannoma, plus meningocele, enteric cyst, lymphoma, diaphragmatic hernia, esophageal tumor, and aortic aneurysm.

Reading it by structures: the anterior compartment contains the thymus and lymph nodes, hence thymic neoplasms, lymphoma, germ cell tumors like teratomas and seminomas and nonseminomas, and thyroid tissue such as ectopic or substernal goiter. The middle compartment contains lymph nodes, pericardium, heart and great vessels, trachea and main bronchi, and esophagus, hence lymphadenopathy from sarcoidosis or lung cancer, lymphoma, benign cystic masses like pericardial and bronchogenic cysts, vascular masses, and esophageal tumors. The posterior compartment contains neural tissue, vertebrae, and lymph nodes, hence neurogenic tumors, meningocele, spinal masses like metastases, and lymphoma. Note that lymph nodes are present in all three compartments, so lymphoma can arise anywhere.

The Thymus and Acute Mediastinitis

Here is a beautiful pediatric pearl. A large thymic silhouette is a normal finding on a frontal chest x-ray in children under three years, often producing the sail sign. In a question stem, if that thymic shadow is missing in a young child, think DiGeorge syndrome or severe combined immunodeficiency, because those kids lack thymic tissue. The thymus normally atrophies and is replaced by fat after puberty, once it has finished producing T lymphocytes. So an adult with a mediastinal opacity on x-ray should undergo workup for a pathologic cause, like lymphoma or a germ cell tumor, because a normal adult thymus should not be visible.

Acute mediastinitis, often after cardiac or esophageal surgery, presents with fever, chest pain, leukocytosis, and mediastinal widening on chest x-ray. The treatment is drainage, debridement, and antibiotics.

Obstructive Lung Disease

Now we hit one of the biggest clinical chapters, obstructive lung disease. The headline diseases are C.O.P.D and asthma, and the key physiologic signature is airflow obstruction, a low F.E.V.1-to-F.V.C ratio. Let's set up a few framing concepts and then dig into each disease.

Digital Clubbing

First, digital clubbing, because it is a high-yield distractor. Clubbing is associated with intrathoracic neoplasms, like bronchogenic carcinoma, metastatic cancers, malignant mesothelioma, and lymphoma; intrathoracic suppurative diseases, like lung abscess, empyema, bronchiectasis, cystic fibrosis, and chronic cavitary infections; lung disease, like idiopathic pulmonary fibrosis, asbestosis, and pulmonary arteriovenous malformations; and cardiovascular disease, like cyanotic congenital heart disease. Here is the trap to avoid: C.O.P.D itself, with or without hypoxemia, does not cause clubbing. So digital clubbing in a C.O.P.D patient should prompt a search for occult malignancy, meaning a chest C.T.

Asthma Versus C.O.P.D on Testing

Lay asthma and C.O.P.D side by side on pulmonary function testing. F.V.C is normal or decreased in both early on, dropping markedly in late-stage C.O.P.D. F.E.V.1 is decreased in both. The F.E.V.1-to-F.V.C ratio is decreased in both. Bronchodilator response is the key separator: reversible in asthma, partially reversible or nonreversible in C.O.P.D, and usually nonreversible in late-stage C.O.P.D. Chest x-ray is normal in both early on, but late-stage C.O.P.D shows hyperinflation and loss of lung markings. D.L.C.O is normal or increased in asthma, and normal or decreased in C.O.P.D, dropping in late-stage C.O.P.D. So reversibility plus D.L.C.O are your discriminators: asthma reverses and keeps its D.L.C.O; C.O.P.D does not reverse and loses its D.L.C.O over time.

Acute Bronchitis

Acute bronchitis is essentially a self-limited viral airway infection that people overtheater. Etiology: a preceding respiratory illness, ninety percent viral. Clinical presentation: cough for more than five days up to three weeks, plus or minus purulent sputum, importantly with absent systemic findings like fever or chills, and wheezing or rhonchi with chest wall tenderness. Diagnosis and treatment: it is a clinical diagnosis, chest x-ray only when pneumonia is suspected, symptomatic treatment with N.S.A.I.D's or bronchodilators, and antibiotics are not recommended.

Two clarifications. Sputum production happens in roughly half of patients, and the yellow or purulent sputum is from epithelial sloughing, not a sign of bacterial infection; small amounts of blood can occur from inflammation and epithelial damage. And the main differential is pneumonia, which has systemic signs of inflammation. So fever and a sick appearance pull you toward pneumonia and away from bronchitis.

C.O.P.D

Now C.O.P.D itself. On physical exam during an acute exacerbation, you may see jugular venous distension during expiration, from increased intrathoracic pressure, along with wheezing, tachypnea, prolonged expiration, and use of accessory muscles. The most common trigger of an exacerbation is an upper respiratory infection.

When should you intubate in a C.O.P.D or asthma exacerbation? Profound acidemia with a pH under seven point one, poor mental status such as somnolence or lack of cooperation, and hemodynamic instability. Otherwise, begin with noninvasive positive-pressure ventilation in respiratory failure, and reserve endotracheal intubation with mechanical ventilation for patients who fail a trial of N.P.P.V.

For an acute exacerbation, the precipitants are infectious about seventy percent of the time, respiratory viruses like rhinovirus and commensal bacteria like nontypeable Haemophilus influenzae, and noninfectious about thirty percent, from sterile inflammation of the underlying disease, pulmonary embolism, or inhaled irritants. The cardinal symptoms are increased dyspnea, increased sputum volume, and increased sputum purulence, with increased work of breathing and impaired gas exchange showing hypoxemia and hypercapnia, while systemic inflammation like fever and leukocytosis is usually absent. Management: maximize expiratory flow with inhaled bronchodilators; reduce airway inflammation with systemic glucocorticoids, I.V or oral, not inhaled; treat triggers with plus or minus antibiotics or antivirals for influenza and covid; maintain oxygenation with an S.p.O.2 target of eighty-eight to ninety-two percent; and maintain ventilation with N.I.P.P.V or invasive mechanical ventilation.

On antibiotics in a C.O.P.D exacerbation, the gold criteria say give antibiotics if any two of the following are present: increased sputum purulence, increased sputum volume, or increased dyspnea. Antibiotics are also recommended for anyone requiring mechanical ventilation, noninvasive or invasive.

Here is a great differential vignette. A patient with an extensive smoking history, coronary artery disease, and hypertension presents with one week of exertional dyspnea, bilateral lung crackles, and occasional wheezes, and the A.B.G shows respiratory alkalosis. The diagnosis is congestive heart failure, not C.O.P.D. Why? C.H.F causes respiratory alkalosis, because pulmonary edema reduces ventilation efficiency, the patient becomes tachypneic, and blows off C-O-two. C.O.P.D, by contrast, causes respiratory acidosis with widespread wheezing, and pulmonary embolism is acute onset. So high C-O-two with respiratory acidosis points to a C.O.P.D exacerbation, while low C-O _{2} with respiratory alkalosis points to a C.H.F exacerbation. That single A.B.G distinction is a frequent test point.

On the chest x-ray, C.O.P.D shows hyperinflation with flattening of the diaphragm; counting more than about eight ribs, or more than ten posterior ribs, indicates hyperinflation. The physical exam consequence is distant heart sounds, best heard at the subxiphoid process, because the hyperinflated lungs push the heart down and away.

Watch for symptomatic hypercapnia in an exacerbation, which should be promptly investigated with an arterial blood gas. The manifestations are predominantly neurologic, headache and hypersomnolence with mild to moderate hypercapnia, and at higher levels, a PaCO _2 above seventy-five to eighty, confusion, lethargy, and eventually coma, the so-called C-O _2 narcosis, or seizures. And severe C.O.P.D is commonly accompanied by pulmonary cachexia, loss of lean muscle mass from energy imbalance and systemic inflammation.

C.O.P.D Treatment

Let's get the treatment philosophy crisp by splitting interventions into those that improve mortality and those that only improve symptoms. The two interventions that improve mortality and delay disease progression are smoking cessation and long-term oxygen therapy, the latter for a resting P.a.O.2 at or under fifty-five, or oxygen saturation at or under eighty-eight percent. If the patient is also in cor pulmonale, with evidence of right heart failure or a hematocrit over fifty-five, the threshold is a P.a.O.2 at or under fifty-nine or saturation at or under eighty-nine.

Vaccinations, influenza and pneumococcal, also help; one source says they reduce mortality, another says they mainly reduce exacerbation rate. The survival benefit of home oxygen is significant when used at least fifteen hours a day. Importantly, if the oxygen saturation is fine, oxygen is not indicated.

The interventions that definitely improve symptoms but do not change disease progression or mortality are short-acting beta agonists like albuterol, anticholinergic agents like tiotropium and ipratropium, steroids, long-acting beta agonists like salmeterol, and pulmonary rehabilitation. A useful escalation rule: an asthmatic not controlled with albuterol goes to an inhaled steroid; a C.O.P.D patient not controlled with albuterol goes to an anticholinergic like tiotropium, then an inhaled steroid. The primary long-term intervention for C.O.P.D is a daily long-acting anticholinergic inhaler, like ipratropium or tiotropium, which may be combined with a short-acting beta agonist for greater symptom relief; inhaled steroids and a long-acting beta agonist are used in more severe C.O.P.D, in contrast to oral or I.V steroids for an acute exacerbation.

For selecting the initial bronchodilator in stable C.O.P.D, the gold groups go like this. Group A, fewer symptoms and few exacerbations, gets a bronchodilator like a short-acting muscarinic antagonist as needed. Group B, more symptoms but still few exacerbations, gets a long-acting beta agonist plus a long-acting muscarinic antagonist. Group E, frequent exacerbations, meaning at least one requiring hospitalization or at least two requiring outpatient systemic corticosteroids, gets a long-acting beta agonist plus a long-acting muscarinic antagonist plus or minus an inhaled corticosteroid. The inhaled corticosteroid is recommended if peripheral blood eosinophilia over three hundred is present, but avoided if there is recurrent pneumonia.

Asthma: Diagnosis

Asthma. The diagnostic flowchart starts with intermittent respiratory symptoms, cough, dyspnea, wheezing, chest tightness, then spirometry. If there is obstruction, an F.E.V.1-to-F.V.C ratio under seventy percent, give an inhaled bronchodilator, a short-acting beta agonist. If it is reversible, defined as at least a twelve percent and two hundred milliliter increase in F.E.V.1 or F.V.C, asthma is confirmed; if nonreversible, think C.O.P.D. If spirometry is normal, do a methacholine bronchoprovocation test; a negative test makes asthma unlikely, prompting an alternate diagnosis like C.H.F, pulmonary hypertension, or vocal cord dysfunction, while a positive test makes asthma possible. So asthma can be diagnosed with a normal or increased D.L.C.O and a greater-than-twelve-percent increase in F.E.V.1 after a bronchodilator, whereas C.O.P.D typically has a decreased D.L.C.O and a less-than-twelve-percent increase.

A sharp clinical case: an inmate who smokes presents with rapidly worsening shortness of breath, tachycardia, tachypnea, and an eighty-seven percent oxygen saturation; he is poorly adherent to his asthma medications and took ibuprofen for shoulder pain the previous night; and there is an urticarial rash over the trunk and extremities. This is anaphylaxis with laryngeal edema, not just an asthma flare. Anaphylaxis may be confused with an asthma exacerbation if the skin involvement is minimal or missed, and N.S.A.I.D's can worsen anaphylaxis. So the rash plus N.S.A.I.D exposure reframes the whole picture.

Learn the flow-volume loops, because they are pure pattern recognition. Upper airway obstruction, such as laryngeal edema, causes flattening of both the top and bottom of the loop, because airflow is limited during both inspiration and expiration, a fixed obstruction. Obstructive lung disease, like asthma, gives a scooped-out expiratory pattern.

And know that gerd exacerbates asthma by three mechanisms: increased vagal tone, heightened bronchial reactivity, and microaspiration of gastric contents into the upper airway. Clues to comorbid gerd in an asthmatic include sore throat, morning hoarseness, a cough that worsens only at night, and increased need for the albuterol inhaler after meals. Proton-pump inhibitor therapy improves both asthma symptoms and peak expiratory flow rate in asthmatics with evidence of comorbid gerd.

Status Asthmaticus

Status asthmaticus, the severe, refractory attack. The features of respiratory failure in acute asthma are clinical, laboratory, and management. Clinically: absent or minimal wheezing because of poor air movement, the ominous silent chest, accessory muscle use, and altered mental status.

Labs: an A.B.G showing poor ventilation, a rising PaCO _2 with falling pH, and poor oxygenation; lactate may transiently rise from increased work of breathing or beta-agonist effect; and potassium may transiently drop from beta agonists and respiratory alkalosis. Management: nebulized albuterol and ipratropium, I.V corticosteroids plus or minus I.V magnesium, a short trial under two hours of N.I.P.P.V, and a low threshold for intubation and invasive mechanical ventilation. Add a one-time infusion of I.V magnesium sulfate for additional bronchodilation if there is no improvement after an hour.

In pregnancy, manage an asthma exacerbation with supplemental oxygen to keep saturation at or above ninety-five percent, nebulized or inhaled albuterol and inhaled ipratropium, systemic corticosteroids if there is an incomplete response, oral preferred like prednisone, and additional therapy with magnesium sulfate or terbutaline if severe, while epinephrine is contraindicated, and intubation for respiratory failure.

Know the risk factors for fatal asthma: in the history, prior respiratory failure requiring N.I.P.P.V, intubation, or I.C.U admission, and poor asthma control with increased inhaler use, frequent oral corticosteroids, or acute care visits; in the clinical status, respirations over thirty a minute, saturation at or under ninety percent, accessory muscle use, altered mental status, a silent chest, an A.B.G with rising or inappropriately normal PaCO _2 relative to the work of breathing, and a peak flow at or under fifty percent of baseline.

The single highest-yield asthma decision: in a severe asthma exacerbation with an elevated PaCO _2 , the next step is endotracheal intubation. Patients with an asthma exacerbation are usually tachypneic, which should give a low C-O _2 , so a normal or elevated PaCO _2 means impending respiratory failure, an inability to meet the increased respiratory demand. And systemic glucocorticoids, like oral prednisone or dexamethasone, reduce the late-phase inflammation in status asthmaticus. Because the anti-inflammatory activity of glucocorticoids is delayed several hours, due to the time required to change nuclear gene expression, they are given alongside bronchodilators in the emergency department, and corticosteroids are continued at home, like prednisone forty to sixty milligrams daily for five to seven days, to prevent relapse and decrease the need for hospitalization.

Occupational and Exercise-Induced Asthma

Occupational asthma. Pathogenesis: workplace antigens trigger inflammation, IgE-dependent or independent, leading to bronchoconstriction. Classic antigens include animal proteins, in animal workers and seafood processors; grain carbohydrates, in bakers; isocyanates, in painters; and metals, in welders. There is a latency of months to years from gradual sensitization. Clinically, symptoms are initially clearly worse at the workplace and relieved at home, but over time they persist through the week and subside only after sustained work absence. Diagnosis requires a detailed occupational history and two-step confirmatory testing: first, confirm asthma, with reversible obstruction on spirometry or, if baseline spirometry is normal, bronchoprovocation with methacholine to confirm bronchial hyperresponsiveness; second, establish the occupational relationship with serial peak expiratory flow rate measurements using a portable meter.

Patients record their peak flow at home and at work, and a peak flow decline of at least twenty percent at the workplace relative to home is consistent with occupational asthma. Management is antigen avoidance or reduction, like a respirator or shift rotation, bronchodilators and inhaled corticosteroids, and desensitization immunotherapy.

Exercise-induced bronchoconstriction. Pathophysiology: hyperventilation leads to incomplete heating and humidification, so cooler, dry air triggers mast cell degranulation and bronchospasm; it can occur in isolation or in underlying asthma. Clinically, decreased exercise tolerance, with asthma symptoms appearing within five to ten minutes and improving after twenty minutes of exercise, the refractory period. Diagnosis: supportive evidence is an empiric response to a pre-exercise bronchodilator, and confirmatory bronchoprovocation testing, with spirometry before and after exercise showing at least a fifteen percent decline in F.E.V.1. Management: improve control of underlying asthma with step-up therapy, premedicate before exercise with inhaled corticosteroid-formoterol ten minutes prior, preferred over a short-acting beta agonist or leukotriene receptor antagonist two hours prior, and daily inhaled corticosteroid-beta agonist or a leukotriene antagonist may be needed for frequent, prolonged exercise. So the first-line treatment for someone who exercises daily is an inhaled corticosteroid or anti-leukotriene agent ten to twenty minutes before exercise, but use a short-acting beta agonist if it is only needed a few times per week.

Asthma Treatment and the Step-Up Strategy

Classify asthma severity in a patient not yet on controller medication. Intermittent: symptoms two days a week or fewer, nighttime awakenings two times a month or fewer, start at step one. Mild persistent: symptoms more than two days a week but not daily, nighttime awakenings three to four times a month, step two.

Moderate persistent: daily symptoms, nighttime awakenings more than once a week but not nightly, step three. Severe persistent: symptoms throughout the day, nighttime awakenings four to seven times a week, step four or five.

I he adult step-up strategy, current style, uses inhaled corticosteroid-formoterol as both reliever and controller. Steps one and two: inhaled corticosteroid-formoterol as needed.

Step three: low-dose inhaled corticosteroid-formoterol daily. Step four: medium-to high-dose inhaled corticosteroid-formoterol daily. Step five: high-dose inhaled corticosteroid-formoterol daily plus a long-acting muscarinic antagonist, and consider biologic therapy, anti-IgE or anti-I.L-5 monoclonal antibodies, if still uncontrolled with frequent need for oral corticosteroids. The reliever throughout is inhaled corticosteroid-formoterol as needed, and adjunctive controller therapies include leukotriene receptor antagonists and allergy immunotherapy.

Know the adverse effects of inhaled corticosteroids. About seventy-five percent of the dose deposits in the oropharynx, causing local effects: dysphonia from steroid-induced laryngeal myopathy, common and usually minor; thrush affecting the tongue and pharynx, rarely the esophagus, which you prevent by rinsing and gargling with water and using a spacer to decrease local deposition; plus contact dermatitis and cough or reflex bronchoconstriction. About twenty-five percent deposits in the peripheral lung and is systemically absorbed, causing systemic effects: H.P.A axis suppression, usually subclinical secondary adrenal insufficiency, which can coexist with inhaled-steroid-induced Cushing syndrome; a small increase in osteoporosis and fracture risk; dermal thinning with fragile skin and purpura; ocular effects like cataract formation and increased intraocular pressure; and a small increased risk of community-acquired pneumonia in C.O.P.D patients. These systemic effects are uncommon, typically seen only with prolonged high-dose use, concurrent oral steroids, or a potent C.Y.P.3.A.4 inhibitor.

And here is a rule worth tattooing on your brain: you cannot give a long-acting beta agonist without an inhaled corticosteroid. A laba as monotherapy increases mortality and is always the wrong answer. If a patient is on a laba, they must be on a steroid; never use a laba first or alone. One more pearl: leukocytosis with a neutrophilic predominance in a patient being treated for an asthma exacerbation is most likely a glucocorticoid side effect, not an infection. And the primary long-term intervention for persistent asthma is a daily inhaled corticosteroid, versus a long-acting anticholinergic inhaler for C.O.P.D.

Bronchiectasis

Bronchiectasis is permanent dilation of the airways. Clinical features: pathophysiology is an airway insult, infection or inhalation, with impaired clearance from mucostasis or immunodeficiency; chronically there is daily production of voluminous, thick, plus or minus blood-tinged mucus; and acute exacerbations bring recurrent infections with mucopurulent sputum plus or minus frank hemoptysis. Etiologies: airway obstruction from cancer or foreign body, and mucostasis from C.F or A.B.P.A; immunodeficiency, like low immunoglobulins, and autoinflammatory disease like Sjogren syndrome; and chronic or past infection, like mycobacteria, or toxic inhalation. Evaluation: a high-resolution C.T of the chest is needed for diagnosis, showing airway dilation; pulmonary function testing shows an obstructive pattern; and you investigate etiologies with immunoglobulin levels, respiratory cultures, and checking for bronchial obstruction. Treatment: address underlying disorders like immunoglobulin replacement, airway clearance with chest physiotherapy and mucolytics, and antibiotics to suppress bacterial overgrowth and treat exacerbations.

Two useful distinctions: focal bronchiectasis is usually due to upstream airway obstruction, like a neoplastic lesion or foreign body, so bronchoscopic airway inspection is required to evaluate it, allowing direct visualization plus diagnostic and therapeutic intervention on the obstructing lesion; whereas diffuse bronchiectasis typically reflects systemic disease, like cystic fibrosis. On imaging, the classic C.T signs are the signet ring sign, where the airway is larger than its accompanying artery, the tram-track sign of airway wall thickening, and a lack of bronchial tapering, with airways dilated into the peripheral one-third of the lung. The best diagnostic test for bronchiectasis is the high-resolution C.T, with characteristic findings of bronchial dilation, lack of airway tapering, and bronchial wall thickening.

Bronchiectasis may resemble chronic bronchitis, but it has more prominent sputum production and its exacerbations are typically bacterial, whereas chronic bronchitis exacerbations are viral. And upper lung lobe involvement is characteristic of bronchiectasis due to C.F, which helps differentiate it from other causes.

Allergic Bronchopulmonary Aspergillosis

Allergic bronchopulmonary aspergillosis, A.B.P.A. Risk factors and pathogenesis: structural airway disease, like asthma or cystic fibrosis, with fungal spore colonization driving T.h.2-based sensitization and allergic inflammation. Clinical features and diagnosis: difficult-to-control asthma with thick sputum; chest imaging showing fleeting infiltrates, bronchiectasis, and bronchial mucoid impaction; and evidence of Aspergillus sensitization, an elevated serum IgE usually over a thousand, a positive Aspergillus skin test or specific IgE, and suggestive findings of eosinophilia and positive Aspergillus IgG. Treatment: systemic glucocorticoids to reduce allergic inflammation, antifungal drugs like voriconazole to reduce spore burden, and treatment of the underlying asthma with bronchodilators. A.B.P.A can be hard to differentiate from C.F pneumonia, and it must be suspected if there is an unexplained lung function decline despite an appropriate antibiotic course of more than a week.

Restrictive Lung Disease

Now we flip to the opposite physiologic pattern: restriction. Where obstruction is about not getting air out, restriction is about not getting the lungs to expand, so the total lung capacity falls and the F.E.V.1-to-F.V.C ratio stays normal. The marquee disease is interstitial lung disease.

Interstitial Lung Disease

Interstitial lung disease, I.L.D. Common etiologies: sarcoidosis, amyloidosis, alveolar proteinosis, vasculitis like granulomatosis with polyangiitis, infection like fungal, tuberculosis, or viral pneumonia, environmental exposure like silicosis and hypersensitivity pneumonitis, connective tissue disease like lupus and scleroderma, and idiopathic pulmonary fibrosis and cryptogenic organizing pneumonia. Clinical presentation: progressive exertional dyspnea, a dry cough, more than fifty percent of patients have a significant smoking history, and fine inspiratory crackles plus or minus digital clubbing. Diagnosis: chest x-ray shows reticulonodular interstitial opacities, the H.R.C.T shows fibrosis, honeycombing, and traction bronchiectasis, and pulmonary function testing shows a restrictive pattern with decreased D.L.C.O.

Two clinical anchors. Inspiratory Velcro crackles, fine and dry, are sensitive for interstitial fibrosis, which is present in many forms of I.L.D. And because early I.L.D may not be visible on chest x-ray, patients with suspected I.L.D should undergo high-resolution C.T, a thin-slice, usually one-millimeter, protocol developed to visualize subtle interstitial features like reticulation and honeycombing. Finally, in I.L.D, hypoxemia, especially with exertion, is more characteristic than hypercapnia, the opposite of C.O.P.D.

Hypersensitivity Pneumonitis

Hypersensitivity pneumonitis is an immunologic response to an inhaled antigen, like mold or animal protein. The acute form gives abrupt-onset fever, chills, cough, dyspnea, fatigue, and leukocytosis, with episodes that are often recurrent and self-resolving, and a chest x-ray showing scattered micronodular interstitial opacities. The chronic form gives progressive cough, dyspnea, fatigue, weight loss, hypoxemia that worsens with exertion, and a chest x-ray showing diffuse reticular interstitial opacities.

Diagnosis: a restrictive pattern on P.F.T's with decreased D.L.C.O in the chronic form, bronchoalveolar lavage showing a high relative lymphocyte count, and lung biopsy showing a lymphocytic infiltrate, poorly formed noncaseating granulomas, and interstitial inflammation or fibrosis in chronic disease. Treatment: remove the antigen exposure, which resolves acute disease, and glucocorticoids and/or lung transplantation for chronic disease. The clue that separates it from an infection like pneumonia is that the acute symptoms recur and resolve within one to two days.

Sarcoidosis

Sarcoidosis is a multisystem granulomatous disease, and you should know its manifestations organ by organ. Pulmonary: hilar lymphadenopathy and interstitial infiltrates. Cutaneous: papules, nodules, plaques, and erythema nodosum. Ophthalmologic: anterior and posterior uveitis, and keratoconjunctivitis sicca.

Neurologic: facial nerve palsy, central diabetes insipidus, and hypogonadotropic hypogonadism. Cardiovascular: A.V block, and dilated or restrictive cardiomyopathy. Gastrointestinal: hepatosplenomegaly and asymptomatic liver function abnormalities.

And other: hypercalcemia, peripheral lymphadenopathy, parotid gland swelling, polyarthritis, and constitutional symptoms like fever and malaise. The combination of fever, erythema nodosum, hilar lymphadenopathy, and polyarthritis is Lofgren syndrome. On chest x-ray you classically see bilateral hilar and mediastinal lymphadenopathy, with a widened mediastinum.

The key points to recite for sarcoidosis: it is common in young, African American females; it presents as shortness of breath on exertion with occasional fine rales on exam but no wheezing; it can be associated with erythema nodosum and lymphadenopathy, and if those are present the diagnosis is likely; the best initial test is a chest x-ray, with hilar adenopathy seen in over ninety-five percent of cases; the most accurate test is a lymph node biopsy looking for noncaseating granulomas; treatment is prednisone, and if the patient is asymptomatic, you do not treat. Although lung involvement like hilar lymphadenopathy is common, it is often, more than fifty percent, asymptomatic, and patients may present with extrapulmonary disease. A nice mnemonic anchor: the suffix -osis tends to cause restrictive disease of some organ, so sarcoidosis can give restrictive lung disease and restrictive heart disease. And if a sarcoidosis patient presents with right upper quadrant pain, think liver involvement, granulomas in the liver.

Pulmonary Hypertension

Pulmonary hypertension is organized into clinical groups, and management follows the group. Group one is pulmonary arterial hypertension: evaluate for autoimmune connective tissue disease, toxins like amphetamines, H.I.V, and schistosomiasis; treat with pulmonary vasodilator therapy and treat the underlying cause. Group two is left-sided heart disease: get an echocardiogram, plus or minus right heart catheterization if unclear, and optimize left ventricular function and treat significant valve disease.

Group three is lung disease or chronic hypoxemia: get pulmonary function tests, chest imaging, and polysomnography, and treat the underlying respiratory condition like obstructive sleep apnea. Group four is chronic thromboembolic pulmonary hypertension: get a V/Q scan and pulmonary angiography, and treat with pulmonary thromboendarterectomy, which is curative, plus anticoagulation. General measures across all groups: refer to an accredited pulmonary hypertension center, maintain normoxia, euvolemia, and sinus rhythm, provide contraceptive counseling, immunization, and cardiac rehabilitation, and consider bilateral lung transplant for refractory disease.

The symptoms reflect a failing right heart: decreased cardiac output causes exertional syncope or presyncope, fatigue, and weakness; increased pulmonary artery pressure causes chest tightness and, rarely, hemoptysis; right ventricular demand ischemia causes exertional angina or tightness; and venous congestion causes abdominal distension, bowel edema, and early satiety. Signs: a precordial heave from right ventricular hypertrophy, a loud P.2, a right-sided S.3 or S.4, a holosystolic murmur of tricuspid regurgitation, and J.V.D, ascites, peripheral edema, and hepatomegaly. The chest x-ray of pulmonary arterial hypertension shows enlarged hila from the dilated pulmonary arteries, because muscular hypertrophy in the pulmonary arteries and arterioles elevates right-sided heart pressures.

For the evaluation flowchart: suspected pulmonary hypertension, with dyspnea, lethargy, and fatigue, leads to echocardiography. If the echo shows left-sided heart disease, get a cardiology consult for that. If not, and clinical suspicion is high, do an exercise echo or right heart catheterization, which confirms pulmonary hypertension if abnormal; if suspicion is low, evaluate for other causes. Based on history, also consider polysomnography, a V/Q scan to rule out chronic thromboembolic disease, pulmonary function studies, H.I.V serology, antinuclear antibodies, rheumatoid factor, and anka in patients with suggestive symptoms, and a urine toxicology for amphetamines.

Obstructive Sleep Apnea

Obstructive sleep apnea. The S.T.O.P-B.A.N.G survey scores eight features, one point each: Snoring, Tiredness, Observed apneas or choking and gasping, high blood Pressure, B.M.I over thirty-five, Age over fifty, Neck size, men over seventeen inches and women over sixteen, and male Gender. Scoring: zero to two points is low risk, three to four intermediate, five or more high risk. S.T.O.P-B.A.N.G has poor positive predictive value but high negative predictive value, so a patient with a score under three is unlikely to have O.S.A and does not require diagnostic testing.

O.S.A patients are at increased risk of perioperative respiratory failure from procedures involving sedation, neuromuscular blockers, opioids, or anesthesia, and when respiratory failure occurs it is from hypoventilation, presenting with hypercapnia and hypoxia. And a practical clinical point: many patients who snore do not have O.S.A; in the absence of other evidence suggesting O.S.A, snoring alone is not an indication for diagnostic testing. Smoking cessation and eliminating alcohol intake before bedtime are the preferred initial management strategies for snoring.

Pneumonia

Now pneumonia, one of the most clinically practical chapters. Let's start with a big-picture flowchart and then refine.

The Pneumonia Roadmap

Picture a patient with fever, cough, and sputum. You check oxygen saturation and a chest x-ray. If there is no infiltrate, you may be dealing with bronchitis, treated with amoxicillin, a cephalosporin, or a fluoroquinolone. If there is an infiltrate, that is pneumonia. If there is cavitation, think tuberculosis, fungus, or a lung abscess, the abscess getting incision and drainage plus clindamycin. With typical symptoms, think Streptococcus pneumoniae, treated with a third-generation cephalosporin if community-acquired or vancomycin if hospital-acquired; with atypical symptoms, think something else, treated with a macrolide if C.A.P or piperacillin-tazobactam if H.A.P. And if the patient has H.I.V or AIDS, think Pneumocystis, with bronchoalveolar lavage, Bactrim, and steroids.

By the most recent I.D.S.A guidelines, pneumonia is classified as community-acquired, developing in a nonhospitalized setting, most commonly Streptococcus pneumoniae; hospital-acquired, developing at least forty-eight hours after admission; and ventilator-acquired, developing at least forty-eight hours after endotracheal intubation.

Community-Acquired Pneumonia in Children

In school-aged children, C.A.P splits by radiographic pattern. A lobar pattern suggests Streptococcus pneumoniae, with abrupt onset of fever, cough, chest pain, increased work of breathing, and focal crackles, treated with oral amoxicillin as an outpatient or I.V ampicillin or ceftriaxone if hospitalized. A bilateral, atypical pattern suggests Mycoplasma pneumoniae or Chlamydia pneumoniae, rarely viruses, with fever, malaise, headache, sore throat, a prolonged gradually worsening cough, a patient who can often continue normal activities, and bilateral crackles and wheezing, treated with a macrolide like azithromycin.

A few pearls. Patients with H.I.V are at increased risk for community-acquired pneumonia. Rusty sputum is classic for pneumococcal pneumonia but may not always be present; it can present with clear sputum, which you only select if there are no viral options in the question. Immunocompromised patients with C.A.P may have no alveolar infiltrate on the initial chest x-ray, due to a blunted cytokine response, so do a C.T scan if C.A.P is suspected and the x-ray is normal.

Recurrent Pneumonia and a Positioning Pearl

Common causes of recurrent pneumonia split by whether it recurs in the same lobe or different lobes. Same lobe: bronchial obstruction, extrinsic from a neoplasm or adenopathy, or intrinsic from bronchiectasis or a foreign body; and recurrent aspiration, from altered consciousness like seizure, sedatives, antipsychotics, alcohol, or illicit drugs, dysphagia from a neurologic disorder or esophageal motility issue, poor dental hygiene, or gastroesophageal reflux. Different lobes: immunodeficiency, like H.I.V, leukemia, or common variable immunodeficiency; sinopulmonary disease, like cystic fibrosis or immotile cilia; and noninfectious causes, like vasculitis or bronchiolitis obliterans with organizing pneumonia.

The imaging point: pneumonia is diagnosed with a chest x-ray, requiring a lobar, interstitial, or cavitary infiltrate, and the x-ray should be acquired before administering empiri. Antibiotics. And the workup pearl: in an older patient with a thirty pack-year smoking history and recurrent episodes of pneumonia in the same anatomic location, order a C.T scan of the chest first, because in patients over fifty with significant smoking history it is essential to evaluate for lung malignancy, and C.T has better sensitivity than chest x-ray. Recurrent pneumonia in the same anatomic location is a red flag for lung cancer.

Now a slick physiology point: why does hypoxemia worsen when a patient with lobar pneumonia lies on the affected side? The answer is increased intrapulmonary shunting. Lying on the affected side increases blood flow, the Q, to that region by gravity, while ventilation, the V, is poor because of the pneumonia, so the V/Q ratio worsens.

With pneumonia down, you get increased perfusion of a poorly ventilated region, increased V/Q mismatch, and worsened hypoxemia; with pneumonia up, decreased perfusion of the poorly ventilated region, decreased V/Q mismatch, and improved hypoxemia. So in unilateral lung disease, good lung down.

Complications and a Look-Alike

What is the likely diagnosis in a patient with pneumonia who has continued symptoms despite adequate antibiotic coverage and loculation on chest x-ray? A complicated parapneumonic effusion, which requires drainage in addition to antibiotics, with chest x-ray to diagnose. The general rule: pneumonia unresponsive to treatment despite adequate antibiotic coverage should prompt evaluation for complications like an effusion or abscess.

Distinguish high-altitude pulmonary edema from multifocal pneumonia, since both cause fever, leukocytosis, hypoxemia, and bilateral lung crackles. High-altitude pulmonary edema features recent arrival at high altitude within a week, absent or mild leukocytosis, a normal procalcitonin, and marked early improvement with oxygen. Multifocal pneumonia features a persistent stay at altitude, leukocytes over fifteen thousand with bands, an elevated procalcitonin, and minimal early improvement with oxygen.

Ventilator-Associated Pneumonia

Ventilator-associated pneumonia is hospital-acquired pneumonia developing more than forty-eight hours after intubation. The evaluation flowchart: suspected V.A.P with an abnormal chest x-ray leads to a lower respiratory tract endotracheal tube sample for culture and microscopy, then empiric antibiotics with gram-positive coverage, antipseudomonal and gram-negative coverage, and consideration of mursa coverage, with empiric coverage depending on the institution's drug-resistance pattern. If cultures are negative, discontinue antibiotics and evaluate for other causes.

If cultures are positive with clinical improvement, narrow the antibiotics per culture results. If cultures are positive without clinical improvement, it is likely V.A.P, so consider changing antibiotics, assess for complications like abscess or empyema, and consider evaluating for other causes. The presentation is pulmonary infiltrates with one or more of fever, purulent secretions, leukocytosis, and difficulty with ventilation.

Major risk factors: acid suppression like P.P.I's, H.2 blockers, or antacids, supine position, pooled subglottic secretions, paralysis and excessive sedation, excessive patient movement while intubated, and frequent ventilator circuit changes.

Aspiration Pneumonia

Aspiration pneumonia. Predisposing conditions: altered consciousness impairing the cough reflex and glottic closure, like dementia or drug intoxication; dysphagia from neurologic deficits like stroke or neurodegenerative disease; upper G.I disorders like gerd; mechanical compromise of aspiration defenses, like nasogastric and endotracheal tubes; protracted vomiting; and large-volume tube feedings in a recumbent position. Grouping the triggers: reduced consciousness from sedatives, antipsychotics, illicit drugs, alcohol, anesthesia, or a generalized seizure; dysphagia from neurologic disorders, esophageal motility defects, protracted vomiting, or gerd; pharyngeal or glottal dysfunction from tracheostomy, intubation, or nasogastric feeding; and dental issues like gingivitis and poor dental hygiene.

Bacterial aspiration pneumonia. Pathophysiology: oropharyngeal or gastric microbes are aspirated into the lungs and overwhelm host defenses by sheer inoculum size. Major risk factors: reduced consciousness like anesthesia, dysphagia like a neuromuscular disorder, impaired glottic closure like intubation, protracted vomiting, and poor dental hygiene.

Clinical features: fever and cough plus or minus foul-smelling sputum, an infiltrate in the dependent portions of the lung, and aerobic plus anaerobic pathogens on sputum studies. Management: if there is no empyema or lung abscess, treat as community-acquired pneumonia; if empyema or lung abscess is present, extend coverage to include anaerobes, like ampicillin-sulbactam. Most patients have foul-smelling sputum and symptoms that progress over one to two weeks.

Prevention strategies in hospitalized patients. Recommended: elevation of the head of the bed to thirty to forty-five degrees, enteral feeding, speech and swallow evaluation, drainage of subglottic secretions in intubated patients, and decontamination of the oropharynx and digestive tract in intubated patients. Not recommended: prokinetic agents, gastrostomy or nasogastric tube placement, gastric volume measurement, and probiotic medications. Aspiration pneumonia prophylaxis can include oral care, diet modification for dysphagia, elevating the head of the bed, and thickened liquids.

A bit of physiology to tie it together: normal swallowing has three airway-protective movements, displacement of the larynx superiorly and anteriorly under the base of the tongue so food is directed posteriorly into the esophagus, tilting of the epiglottis to block the airway, and closing of the glottis by adduction of the vocal folds. Because swallowing is so complex, stroke patients often have persistent dysphagia and aspiration, and if the neurologic deficit cannot be corrected, behavioral modifications can improve swallowing safety. A chin-tuck maneuver, flexing the head and neck during swallowing, decreases the distance from the hyoid bone to the larynx, simulating elevation of the larynx, and narrows the laryngeal entrance, reducing aspiration.

Recurrent Pneumonia by Etiology and Treatment

Recurrent pneumonia by etiology and clinical features. Aspiration, from seizures, dysphagia, or alcohol intoxication: anaerobes and polymicrobial organisms, right middle or lower lobe involvement, dysphagia, dysarthria, and altered mentation. Chronic obstructive lung disease, including chronic bronchitis, emphysema, asthma, and bronchiectasis: Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Pseudomonas especially in bronchiectasis, and viruses, with a smoking history, chronic cough, and chronic dyspnea.

Immunodeficiency, from H.I.V, primary immune deficiency, hypogammaglobulinemia, or hematologic malignancy: Streptococcus pneumoniae, Haemophilus influenzae, Pneumocystis, and atypical organisms. Post-obstructive: polymicrobial, with hemoptysis, weight loss or cachexia, and pneumonia in the same location. Tuberculosis: Mycobacterium tuberculosis, with upper-lobe or apical disease, in a recent immigrant, institutionalized patient, or someone homeless or of lower socioeconomic status.

Pneumonia Treatment and C.U.R.B-65

Empiric treatment of C.A.P. Outpatient: a macrolide or doxycycline in a healthy patient, or a fluoroquinolone or a beta-lactam plus a macrolide if comorbidities. Inpatient, non-I.C.U: a fluoroquinolone I.V, or a beta-lactam plus a macrolide 4. Inpatient, I.C.U: a beta-lactam plus a macrolide I.V, or a beta-lactam plus a fluoroquinolone 4. The most common cause is Streptococcus pneumoniae.

C.U.R.B-65 determines the need for hospitalization, one point each for Confusion, Urea over twenty, Respirations at least thirty a minute, low Blood pressure with systolic under ninety or diastolic at or under sixty, and Age at least sixty-five. A score of zero is low mortality, outpatient treatment; one to two is intermediate, likely inpatient; three to four is high mortality, urgent inpatient admission, possibly I.C.U if the score is over four.

The outpatient C.A.P treatment flowchart, framed by allergy: if the patient can tolerate penicillins, give amoxicillin or amoxicillin-clavulanate plus a macrolide, preferred, or doxycycline. Use amoxicillin-clavulanate when risk factors for severe disease are present, like smoking, age over sixty-five, recent antibiotics, major comorbidities, or alcohol use disorder. If they cannot tolerate penicillins but can tolerate cephalosporins, give a third-generation cephalosporin plus a macrolide, preferred, or doxycycline. If neither, give a respiratory fluoroquinolone. For hospital-acquired pneumonia, the regimen is vancomycin plus piperacillin-tazobactam.

Two cautions. Fluoroquinolones like levofloxacin and moxifloxacin that target respiratory organisms can also be used for C.A.P in the inpatient setting, but this class is generally avoided when possible in elderly patients because of increased risk of Clostridium difficile infection, tendon rupture, and aortic dissection. And empiric treatment of pneumonia in a young child with cystic fibrosis should include coverage against methicillin-resistant Staphylococcus aureus, for example 4 vancomycin. In cystic fibrosis, bacterial colonization shifts with age: Staphylococcus aureus dominates in young children, while Pseudomonas aeruginosa becomes more common with increasing age.

Pleural Effusion

Let's talk about fluid in the pleural space. The whole game here is dividing fluid into transudate versus exudate, and recognizing when an effusion related to pneumonia has become dangerous and needs draining.

Parapneumonic Effusions and Empyema

Parapneumonic effusions come in uncomplicated and complicated forms. An uncomplicated effusion is a sterile exudate in the pleural space, with a pH at or above seven point two, glucose at or above sixty, a white count at or under fifty thousand, a negative gram stain and culture, and treatment with antibiotics alone. A complicated effusion is from bacterial invasion of the pleural space, with a pH under seven point two, glucose under sixty, a white count over fifty thousand, a gram stain and culture that are negative but often falsely negative due to low bacterial count, and treatment with antibiotics plus drainage. When you add an empyema, both gram stain and culture are typically positive.

The management flowchart: pneumonia with an effusion on chest x-ray. A small effusion with no respiratory distress or hypoxia gets oral antibiotics and close monitoring. A moderate to large effusion, or respiratory distress, or hypoxia, gets ultrasound, I.V antibiotics, and drainage.

Compare the three side by side. An uncomplicated parapneumonic effusion: inflammatory fluid from pneumonia entering the pleural space, pH around seven point two with normal or slightly low glucose, an L.D.H ratio over zero point six, and a negative gram stain. A complicated parapneumonic effusion: bacterial invasion into the pleural fluid, pH under seven point two with low glucose, L.D.H ratio over zero point six, and a gram stain that can be positive or negative. An empyema: bacterial colonization producing frankly purulent fluid, pH under seven point two with low glucose, L.D.H ratio over zero point six, and a positive gram stain. So a positive gram stain and culture distinguishes empyema from a complicated effusion, and both are managed with antibiotics and drainage.

The pathophysiology is worth understanding. An uncomplicated parapneumonic effusion forms when lung interstitial fluid increases during pneumonia and crosses the visceral pleura, giving exudative chemistry and a neutrophil influx. A complicated effusion develops with bacterial invasion of the pleural space, which raises neutrophils and produces pleural fluid acidosis, from anaerobic use of glucose by neutrophils and bacteria, while lysis of neutrophils raises the L.D.H, often above a thousand. Normal pleural fluid pH is about seven point six. Exudative effusions tend to have a lower pH, seven point three to seven point four five, while transudative effusions have a higher pH, seven point four to seven point five five.

Working Up an Undiagnosed Effusion

What is the next step for a smoker with progressive dyspnea, weight loss, and a pleural effusion on chest x-ray? A diagnostic thoracentesis, because an undiagnosed pleural effusion is best evaluated by sampling the fluid to determine whether it is transudative or exudative. The exception is a patient with clear evidence of C.H.F, like weight gain, pedal edema, and bibasilar crackles, where the first step is a trial of diuretics, and you can quickly support C.H.F with a B.N.P level, above five hundred suggesting C.H.F.

Two useful nuggets on lymphocyte-rich effusions. The etiologies of a pleural effusion with a high lymphocytic count over fifty percent are cancer, tuberculosis, and fungus. And a high lymphocyte count with a high adenosine deaminase points to tuberculosis. Tuberculous pleural effusions are typically lymphocytic and exudative with an elevated adenosine deaminase level; smears are often negative for acid-fast bacilli, so diagnosis usually requires pleural biopsy with histopathologic demonstration of pleural granulomas.

Now Light's criteria, the framework for transudate versus exudate. A fluid is exudative if any one of these is met: pleural fluid protein to serum protein ratio over zero point five, pleural fluid L.D.H to serum L.D.H ratio over zero point six, or pleural fluid L.D.H greater than two-thirds the upper limit of normal serum L.D.H. On physical characteristics, a transudate does not froth or form clots and has a specific gravity at or under one point zero one six, glucose at or above sixty, cholesterol under sixty, and total protein at or under thirty grams per liter; an exudate is straw-colored fluid that may rarely be hemorrhagic, froths on shaking, and forms clots on standing, with a specific gravity over one point zero one six, glucose interpreted by level, cholesterol at or above sixty which is strongly elevated in chylothorax, and total protein over thirty grams per liter. On glucose specifically: thirty to sixty suggests malignant effusion, tuberculous pleurisy, empyema, pneumonia, esophageal rupture, or lupus pleuritis, and under thirty suggests rheumatoid pleurisy or empyema. And a key alarm: pleural fluid with a bloody appearance suggests a malignant etiology.

Pediatric empyema. Etiology: bacterial invasion of the pleural space resulting in fibrinopurulent consolidation. Common organisms: Streptococcus pneumoniae and Staphylococcus aureus, including mursa. Clinical features: pneumonia symptoms like fever, dyspnea, and pleuritic chest pain, no improvement with routine pneumonia treatment, signs of a pleural effusion like dullness to percussion, and laboratory evidence of inflammation like leukocytosis and thrombocytosis. Management: supportive care, empiric antibiotics plus drainage with a chest tube or surgery, and intrapleural fibrinolytics may aid drainage; ceftriaxone plus vancomycin or clindamycin.

Exudative effusions, summarized by Light's criteria, have etiologies of empyema, which is purulent, neutrophil-predominant, with a positive gram stain or culture, chylothorax, which is milky white with high triglycerides, malignancy, with abnormal cytology, and tuberculosis, with a positive acid-fast bacterium stain or culture. A special cause: a pancreaticopleural fistula, a connection between the pancreatic duct and the pleural space, gives an amylase-rich exudative effusion, most commonly from acute or chronic pancreatitis; management includes bowel rest to promote fistula closure, and endoscopic retrograde cholangiopancreatography with sphincterotomy may be required to drain pancreatic fluid through the ampulla of Vater rather than the fistula. The differential is Boerhaave syndrome, where the pleural fluid pH is very low, under six.

Lung Abscess

A lung abscess. Pathophysiology: aspiration of oropharyngeal or gingival anaerobes, with risk factors of dysphagia, substance abuse, and seizures, progressing from pneumonitis to pneumonia to abscess or empyema. Manifestations: subacute fever, night sweats, weight loss, and cough with putrid sputum. Diagnosis: cavitary infiltrates with air-fluid levels, and cultures are rarely useful.

Treatment: ampicillin-sulbactam, imipenem, or meropenem, with clindamycin as an alternate. The key points: abscesses do not form out of nowhere, these patients have an aspiration risk; empiric treatment with ampicillin-sulbactam is recommended because most lung abscesses involve anaerobes; the aspiration risk is typically secondary to seizure, alcoholism, multiple sclerosis, or stroke; and you tailor treatment once culture and sensitivity return. On chest x-ray you see an air-fluid level, and on C.T you see consolidation with an air-fluid level, often with a thick abscess wall.

Pneumothorax

Air in the pleural space, the pneumothorax. The crucial split is spontaneous versus tension, because tension is a true emergency.

Spontaneous and Tension Pneumothorax

Compare them across four domains. Associated features: spontaneous can be primary, with no preceding event or lung disease, in thin young men, or secondary to underlying lung disease like C.O.P.D; tension is life-threatening and often due to trauma or mechanical ventilation. Signs and symptoms: spontaneous gives chest pain, dyspnea, decreased breath sounds, decreased chest movement, and ipsilateral hyperresonance to percussion; tension adds hemodynamic instability and tracheal deviation away from the affected side.

Imaging: spontaneous shows absent lung markings and a visceral pleural line; tension adds a contralateral mediastinal shift and ipsilateral hemidiaphragm flattening. Management: a small spontaneous pneumothorax, two centimeters or less, gets observation and oxygen, while a large and stable one gets needle aspiration or a chest tube; a tension pneumothorax needs urgent needle decompression or chest tube placement. On a chest x-ray, the tell is radiolucent air with no lung markings and a collapsed lung edge, the visceral pleural line.

Two great vignettes. A patient on a ventilator who develops hypotension, tachycardia, and unilateral absence of breath sounds has a pneumothorax. And a premature infant with unilateral absence of breath sounds, heart sounds on the right, and increased transillumination on the left side of the chest has a tension pneumothorax on the left side. The illumination test can diagnose it quickly in infants, or a chest x-ray if uncertain; the left pneumothorax has pushed the heart to the right, so urgent needle decompression is needed.

Some connecting pearls. Meconium aspiration syndrome, most common in post-mature neonates, is associated with pneumothorax because meconium plugging of airways traps distal gas and promotes alveolar overdistension and rupture. Bedside ultrasonography can be performed rapidly and has high sensitivity and specificity for pneumothorax, and it has become the test of choice for evaluating tension pneumothorax in the acute setting, like a trauma bay or I.C.U. And the rule that must not be violated: intubation is contraindicated in a patient with a pneumothorax; put in a tube or needle first, because positive pressure will convert it to a tension pneumothorax.

Spontaneous Pneumomediastinum

Spontaneous pneumomediastinum. Risk factors: an asthma exacerbation, respiratory infection, and being a tall, thin, adolescent boy. Clinical features: acute chest pain, shortness of breath, and cough, subcutaneous emphysema, and Hamman sign, a crunching sound over the heart synchronized with the heartbeat. Diagnosis: mediastinal gas on chest x-ray. Treatment: rest, analgesics, and avoidance of Valsalva maneuvers. You may see both pneumomediastinum and pneumopericardium on the film.

Pulmonary Embolism

Pulmonary embolism is huge, so let's build the diagnostic and treatment logic carefully, because exam questions live on the decision points.

The Approach to Suspected P.E

The overall approach: first stabilize the patient with oxygen and I.V fluids. Then evaluate for absolute contraindications to anticoagulation. If there are absolute contraindications, obtain a diagnostic test to evaluate for P.E; if positive, consider an I.V.C filter, and if negative, no further evaluation is needed. If there are no absolute contraindications, assess clinical suspicion with the modified Wells criteria. If P.E is unlikely, you proceed down the testing path. If P.E is likely, consider anticoagulation, especially if there are no relative contraindications and the patient has moderate to severe distress, then obtain a diagnostic test; if positive, start or continue anticoagulation and consider surgery or thrombolytics if indicated; if negative, stop anticoagulation. The key teaching point: if there is no contraindication to anticoagulation, it should precede diagnostic imaging in patients with a likely P.E, especially when they are in moderate distress.

Diagnostic Strategy and Wells Criteria

The diagnostic strategy uses the modified Wells criteria for pretest probability. If P.E is unlikely, get a D-dimer; at or under five hundred, P.E is excluded, while over five hundred prompts C.T pulmonary angiography. If P.E is likely, go straight to C.T pulmonary angiography; a negative C.T excludes P.E, a positive C.T confirms it. So the rule of thumb: greater than four points means P.E likely, so immediate anticoagulation and C.T angiography; four or fewer means P.E unlikely, so D-dimer, and only proceed to C.T angiography if the D-dimer is positive, with reassurance if it is negative.

The modified Wells criteria assign points: three points for clinical signs of D.V.T and for an alternate diagnosis being less likely than P.E; one and a half points each for a previous P.E or D.V.T, a heart rate over a hundred, and recent surgery or immobilization; and one point each for hemoptysis and cancer. A total of four or fewer is P.E unlikely, over four is P.E likely.

A separate, more hemodynamic flowchart: suspected P.E that is hemodynamically stable goes to determining pretest probability, with low or intermediate probability getting a D-dimer screen, a negative one excluding P.E and a positive one prompting confirmatory C.T angiography or V/Q scan, and high probability going directly to confirmatory testing. Hemodynamically unstable P.E goes to assessing the right ventricle with emergent transthoracic echocardiography; new R.V dysfunction with dilation or hypokinesis means a presumed massive P.E, while a normal R.V prompts evaluation for other causes of shock.

Predictors of thirty-day mortality in P.E: clinically, hypotension with systolic blood pressure under ninety, tachycardia over a hundred ten, tachypnea over thirty, hypothermia under thirty Celsius, hypoxemia under ninety percent, altered mental status, a history of cancer, and age over eighty; radiologically, right ventricular dysfunction; and in the lab, an elevated troponin and brain natriuretic peptide. The big in-hospital mortality risk factors are advanced age and obstructive shock.

Diagnostic Details and Massive P.E

The test of choice to diagnose P.E in a clinically stable patient with a high likelihood, modified Wells over four, is C.T angiography. In patients with low likelihood, Wells four or fewer, D-dimer testing can rule out P.E because of its high negative predictive value. If a patient is thought to have a P.E but cannot tolerate I.V contrast due to severe renal disease, the alternative is a V/Q scan, which is also done in pregnant patients to avoid fetal radiation.

The pathophysiology of submassive and massive P.E is a cascade. A massive P.E causes right ventricular outflow obstruction and increased R.V pressure, leading to R.V hypokinesis and dilation. That causes decreased R.V cardiac output with septal deviation toward the left ventricle, and increased R.V wall tension with increased R.V myocardial oxygen demand, leading to R.V ischemia and infarction. The septal deviation and reduced R.V output decrease L.V preload and cardiac output, and the R.V ischemia reflects decreased coronary perfusion and R.V myocardial supply. Patients with acute massive P.E can present with syncope and hemodynamic collapse.

A classic vignette: a postoperative patient with hypotension, J.V.D, and a new-onset right bundle branch block has a massive pulmonary embolism, because massive P.E is defined as P.E complicated by hypotension and/or acute right heart strain, such as J.V.D and a right bundle branch block.

P.E Management

Management options for P.E. Anticoagulation for all patients unless there is a specific contraindication. An inferior vena cava filter when anticoagulation is contraindicated or ineffective, or there is low cardiopulmonary reserve. Thrombolysis for a P.E with hypotension, systolic under ninety, and low bleeding risk. And embolectomy, percutaneous or surgical, when shock is likely to cause death within hours, or when thrombolysis has failed or is contraindicated and there is persistent hypotension.

By classification: low-risk P.E, with no R.V dysfunction and no hypotension and a systolic at or above ninety, gets anticoagulation unless contraindicated. Submassive P.E, with R.V dysfunction by dilation or hypokinesis, plus higher-risk features like elevated biomarkers such as troponin or B.N.P, but no hypotension, gets individualized strategies, ranging from anticoagulation to tailored, possibly catheter-directed, thrombolysis if higher risk. Massive P.E, with R.V dysfunction and hypotension, systolic under ninety, gets systemic thrombolysis and/or embolectomy.

Two distinguishing pearls. Acute P.E may present with syncope due to right ventricular dysfunction, cardiac arrhythmia, or a vasovagal response, and can also present with mild atelectasis and a bloody pleural effusion. And it may be difficult to differentiate P.E from right ventricular myocardial infarction, which can also cause R.V dysfunction; however, R.V myocardial infarction is less likely to cause dyspnea or syncope and more likely to cause bradycardia or arrhythmias.

P.E on Imaging and E.C.G

Learn the radiographic signs. Hampton's hump is a wedge-shaped peripheral opacity representing a pulmonary infarct, virtually pathognomonic for P.E, often with an ipsilateral pleural effusion. The Fleischner sign is a proximal enlargement of the pulmonary artery.

The Westermark sign is an abrupt pulmonary artery cutoff with decreased distal vascular markings. The chest x-ray may also show nonspecific findings like atelectasis and pleural effusion. Patients with P.E commonly develop small pleural effusions from hemorrhage or inflammation, which tend to be exudative and grossly bloody and can be associated with pain from pleural irritation, with leukocytosis or peripheral neutrophilia as in any acute inflammatory process.

Acute P.E causes fever in roughly fifteen percent of cases, possibly from tissue necrosis in the setting of pulmonary infarction.

On E.C.G, the classically associated finding is S.1.Q.3.T.3, a prominent S in lead one, a Q wave in lead three, and T-wave inversion in lead three, indicative of right heart strain, along with S.T depression and T-wave inversion in the right leads, aVR, two, V.5, and V.6. But this is rarely seen; sinus tachycardia is the most common E.C.G finding. The common symptoms of P.E are acute-onset dyspnea, pleuritic chest pain, and atrial fibrillation, the last from atrial dilation.

Deep Vein Thrombosis

Deep vein thrombosis. The diagnostic test of choice for a patient with a moderate-to-high probability of D.V.T, modified Wells over two, is compression ultrasonography; you may use D-dimer in patients with low pretest probability, and the diagnosis should be confirmed before anticoagulation is started. The modified Wells criteria for D.V.T pretest probability score one point each for previously documented D.V.T, active cancer, recent immobilization of the legs, recently bedridden over three days, localized tenderness along a vein, a swollen leg, calf swelling over three centimeters compared to the other leg, pitting edema, and collateral superficial nonvaricose veins, with minus two points if an alternate diagnosis is more likely; zero is low probability, one to two moderate, three or more high.

Upper extremity deep venous thrombosis. Risk factors: central venous catheters, repetitive arm motions like baseball pitching, weight lifting, and malignancy. Manifestations: acute arm edema, heaviness, pain, and erythema, dilated subcutaneous collateral veins in the chest or upper extremity, and pulmonary embolism.

Diagnosis: duplex or Doppler ultrasonography. Treatment: three months of anticoagulation, and thrombolysis for non-catheter-related cases. In upper-arm D.V.T, the catheter site is clean with swelling of the arm. And patients who inject drugs into the femoral vein can develop D.V.T from iliofemoral venous wall trauma, chemical irritation, and infection.

Management of lower extremity proximal D.V.T, above the knee. First ask whether it is a limb-threatening D.V.T, with compartment syndrome or phlegmasia cerulea dolens, where a large occlusive iliofemoral D.V.T causes venous limb ischemia and gangrene, with cyanosis, bullae, massive edema, and extreme pain; if yes, do thrombolysis or thrombectomy, systemic or catheter-directed, or percutaneous or surgical. If not limb-threatening, ask whether anticoagulation is contraindicated, by active or difficult-to-treat major bleeding or intracranial hemorrhage; if yes, place an I.V.C filter, retrievable preferred; if no, anticoagulate.

Treatment of acute D.V.T or P.E compares oral factor Xa inhibitors and warfarin. Oral factor Xa inhibitors: direct factor Xa inhibition, therapeutic onset in two to four hours, no overlap needed, and no laboratory monitoring. Warfarin: vitamin K antagonism, therapeutic onset in five to seven days, requires overlap with unfractionated or low-molecular-weight heparin for about five days, and requires P.T/I.N.R monitoring. A key caveat: I.V.C filters are inherently thrombogenic; although they halve the risk of recurrent P.E, they double the risk of recurrent D.V.T, an increase intrinsic to the filter itself, from the thrombogenic mesh surface and venous stasis.

More pearls. The most common source of symptomatic P.E is the proximal deep leg veins, the femoral, popliteal, and iliac veins, while distal veins like the calf veins are less likely to embolize. In an older patient with a first episode of D.V.T and no history of immobilization, surgery, or provocative medications, you must rule out malignancy, with age-appropriate cancer screening like colonoscopy and mammogram and a chest x-ray, plus more detailed testing depending on symptoms; test for inherited causes like protein C deficiency if the patient is under forty-five, has multiple sites, or a family history. And in a patient who develops a D.V.T from a reversible or time-limited risk factor, like surgery, pregnancy, oral contraceptive use, or trauma, warfarin anticoagulation should be continued for a minimum of three months, but treatment beyond six months is not necessary.

Air Embolism

Venous air embolism. Etiologies: trauma, certain surgeries like neurosurgical, central venous catheter manipulation, and barotrauma like positive-pressure ventilation. Clinical manifestations: sudden-onset respiratory distress, hypoxemia, obstructive shock, and cardiac arrest. Management: left lateral decubitus positioning, and high-flow or hyperbaric oxygen. A small venous air embolism often causes minimal sequelae, traveling to the pulmonary capillaries where it diffuses into the alveoli without consequence; however, a large one, say over fifty milliliters, can lodge in the right ventricle to cause right ventricular outflow tract obstruction, or lodge in the pulmonary arterioles to obstruct pulmonary blood flow. The left lateral decubitus position works by trapping the air on the lateral wall of the right ventricle, preventing it from reaching and obstructing the outflow tract.

Arterial air embolism is different: its manifestations include stroke and myocardial infarction. Air can pass into the arterial circulation by overwhelming the pulmonary capillary filtering capacity or via a right-to-left shunt like a patent foramen ovale. Small arterial air bubbles can travel to the brain to cause confusion, gait ataxia, and dysarthria, and a small volume, one to two milliliters, can cause a localized stroke like left arm weakness or a myocardial infarction. Patients with suspected arterial air embolism should be placed supine, which helps prevent the embolism from traveling to the brain and causing a stroke. Emergency treatment is I.V hydration, Trendelenburg positioning, and a hundred percent oxygen, with hyperbaric oxygen therapy being optimal.

Fat Embolism

Fat embolism syndrome. Etiology: fractures of marrow-containing bones like the femur and pelvis, orthopedic procedures, pancreatitis, and sickle cell disease. Clinical presentation: onset usually twenty-four to seventy-two hours following the inciting event, with the classic triad of respiratory distress in over ninety percent, hypoxemia, dyspnea, and tachypnea; neurologic dysfunction in over fifty percent, altered mentation and seizures; and a petechial rash in under fifty percent, on the head, trunk, and subconjunctiva.

Diagnosis is based on clinical presentation. Prevention and treatment: early fracture immobilization and fixation, and supportive care.

A.R.D.S

Acute respiratory distress syndrome is the severe end of acute lung injury, and the management has a very specific, testable logic, so let's build it carefully.

Pathogenesis and Diagnosis

Pathogenesis. Risk factors are direct lung injury, like pneumonia or inhalation, or indirect injury, like sepsis, pancreatitis, or trauma, with inflammatory cell activation and increased permeability leading to fluid and cytokine leakage into the alveoli.

Pathophysiology: decreased lung compliance from alveolar flooding increases the work of breathing; severe V/Q mismatch, essentially an intrapulmonary shunt, causes severe hypoxemia; and increased hypoxic pulmonary vasoconstriction raises right ventricular afterload and causes acute pulmonary hypertension. Diagnosis: new bilateral alveolar opacities within one week of an inciting insult, edema not explained by cardiac failure or volume overload, and hypoxemia with a P.a.O.2-to-F.i.O.2 ratio at or under three hundred.

Management and Prognosis

Management and prognosis. Mechanical ventilation centers on lung protection: limit the alveolar distending volume to a tidal volume around six milliliters per kilogram and the plateau pressure to at or under thirty centimeters of water; tolerate permissive hypercapnia, meaning a rising PaCO _2 and falling pH are acceptable to avoid excessive tidal volumes; and for oxygenation, set the lowest feasible FiO _2 with a goal SpO _2 of ninety-two to ninety-six percent to avoid oxygen toxicity. Supportive care: treat the underlying etiology, like source control in sepsis; prevent iatrogenic harm with a negative fluid balance, timely extubation, and minimized sedation; and consider corticosteroids in select patients with moderate-to-severe early A.R.D.S. Prognosis: a mortality rate around forty percent in hospital, with death mostly due to multiorgan failure, and a morbidity rate of fifty percent with chronic cognitive impairment and physical debility, and twenty-five percent with chronic pulmonary dysfunction, meaning restriction and a decreased D.L.C.O.

Initial Ventilator Management and Key Concepts

The initial ventilator management flowchart after intubation: set initial settings of F.i.O.2 a hundred percent, peep five, tidal volume six milliliters per kilogram of ideal body weight, and a respiratory rate of fourteen to eighteen a minute. Then adjust oxygenation, decreasing F.i.O.2 if the P.a.O.2 is over ninety, hyperoxia, and increasing peep if the P.a.O.2 is under sixty, hypoxia. And adjust ventilation, increasing the respiratory rate, and the tidal volume only as a last resort, if the P.a.C.O.2 is high with a pH under seven point two five, and decreasing the tidal volume and rate, increasing sedation as a last resort, if the P.a.C.O.2 is low with a pH at or above seven point four five.

Throughout, ensure lung-protective ventilation to avoid alveolar overdistension, evaluating compliance by measuring the plateau pressure with an inspiratory hold, with a goal plateau pressure at or under thirty, decreasing the tidal volume and/or adjusting peep as needed.

Define the P.a.O.2-to-F.i.O.2 ratio, a clinical indicator of hypoxemia, the ratio of oxygen tension in blood to the fraction of inspired oxygen, normally about zero point two one in room air. Normal is three hundred to five hundred; under three hundred is A.R.D.S, with a hundred indicating severe A.R.D.S. Mechanical ventilation in A.R.D.S should use low tidal volumes and high peep, because a significant number of alveoli remain collapsed despite positive pressure, and any tidal volume delivered is distributed to the alveoli that remain open, the functional baby lung; low tidal volume ventilation prevents overdistension of those alveoli and improves mortality, with a peep of at least ten. Prone positioning distributes ventilation from the ventral to the dorsal, dependent lung regions, where most alveoli are located, improving the homogeneity of ventilation throughout the lungs and decreasing mortality in A.R.D.S.

On fluids: fluid balance is the net sum of all intake and output from admission, and A.R.D.S patients often have an initial positive balance from volume resuscitation for sepsis or blood transfusion for trauma. During hospitalization, a conservative fluid strategy aimed at a neutral or negative balance accelerates recovery from A.R.D.S and trends toward improved survival, the dry lungs are happy lungs idea. You accomplish this by minimizing intake, avoiding unnecessary fluid boluses and concentrating I.V drips, and promoting removal with diuretics or renal replacement therapy. Patients with refractory hypotension, like septic shock, should be assessed for fluid responsiveness before blind volume loading, for example with a passive leg raise to simulate a fluid bolus, and vasopressors like norepinephrine may be required to support hemodynamics so that volume can be removed.

Lung Cancer

Now lung cancer, where the exam wants you to know the cell types, their locations, and their paraneoplastic syndromes, plus how to handle a solitary pulmonary nodule and the operability question.

Operability and Cell Types

A lobectomy is the standard surgical approach to lung cancer and can be tolerated if the F.E.V.1 is over one point five liters and the D.L.C.O is over sixty percent. F.E.V.1 and D.L.C.O, obtained by preoperative pulmonary function testing, are the best predictors of postoperative outcomes after lung resection.

The four major lung cancer types, by incidence, location, and clinical associations. Adenocarcinoma, forty to fifty percent, peripheral, associated with clubbing and hypertrophic osteoarthropathy. Squamous cell carcinoma, twenty to twenty-five percent, central, with necrosis and cavitation, and hypercalcemia from P.T.H-related peptide. Small cell carcinoma, ten to fifteen percent, central, with Cushing syndrome, S.I.A.D.H, and Lambert-Eaton syndrome. Large cell carcinoma, five to ten percent, peripheral, with gynecomastia and galactorrhea. So central with cavitation and high calcium is squamous; central with the endocrine and neurologic paraneoplastic syndromes is small cell; peripheral with clubbing is adeno; peripheral with gynecomastia is large cell.

The Solitary Pulmonary Nodule

Assessing malignancy risk for a solitary pulmonary nodule uses several variables, scaled low, intermediate, and high risk. Nodule size: under zero point eight centimeters is low, zero point eight to two intermediate, two or more high. Age: under forty low, forty to sixty intermediate, over sixty high.

Smoking status: never smoked low, current intermediate or high. Smoking cessation: over fifteen years low, five to fifteen intermediate, under five high. Nodule margins: smooth low, scalloped intermediate, corona radiata or spiculated high.

Two flowcharts. First: a solitary pulmonary nodule on routine chest x-ray. Check for a previous chest x-ray; a stable lesion over two to three years means no further testing. No previous imaging or possible nodule growth means a chest C.T. From the C.T, benign features get serial C.T scans, indeterminate or suspicious lesions get further investigation with biopsy or P.E.T, and highly suspicious lesions get surgical excision. The clean rule: if a solid lesion on prior imaging is stable in size for over two years, malignancy is effectively ruled out and no further testing is necessary.

Second flowchart: a solitary pulmonary nodule with high malignancy risk goes to surgical excision; low to intermediate risk is sorted by nodule size. At least eight millimeters gets FDG-P.E.T or biopsy, with suspicious findings going to surgical excision and not-suspicious findings going to serial C.T scans. Under eight millimeters is further stratified, with five to seven millimeters being intermediate risk going to serial C.T scans, and four millimeters or less being low risk with no follow-up.

On calcification patterns: certain patterns within a pulmonary nodule strongly suggest benign lesions, including popcorn, concentric or laminated, central, and diffuse homo-jee-nee-us calcifications; popcorn calcification is characteristically seen in pulmonary hamartoma. By contrast, eccentric calcification, an area of asymmetric calcification, as well as reticular or punctate calcification, should raise suspicion for malignancy. On a chest x-ray, squamous cell carcinoma of the lung can appear as a cavitary lesion with an air-fluid level.

Pancoast Tumor and Carcinoid

A Pancoast tumor sits at the lung apex, and its clinical presentation is distinctive: shoulder pain, the most common feature; Horner syndrome, ipsilateral ptosis, miosis, enophthalmos, and anhidrosis, from involvement of the paravertebral sympathetic chain and the inferior cervical ganglion; C.8 to T.2 neurologic involvement, with weakness or atrophy of intrinsic hand muscles and pain and paresthesias of the fourth and fifth digits and the medial arm and forearm; supraclavicular lymph node enlargement; and weight loss.

The bronchial carcinoid tumor. Epidemiology: the most common lung cancer in adolescents and young adults, a neuroendocrine tumor derived from bronchial Kulchitsky cells. Manifestations: proximal airway obstruction with dyspnea, wheezing, and cough; recurrent pneumonia distal to the obstruction; hemoptysis; and carcinoid syndrome, which is less common than with midgut carcinoid. Diagnosis: chest imaging showing a contrast-enhanced, vascular tumor with an endobronchial component, and bronchoscopy with biopsy.

Head and Neck Cancer

For head and neck cancer, the best initial test in a patient found to have a cervical lymph node with metastatic squamous cell carcinoma is panendoscopy, esophagoscopy, bronchoscopy, and laryngoscopy, which helps detect the primary tumor so it can be biopsied to determine further management. Head and neck cancer can present with cervical lymph node enlargement or referred otalgia, ear pain, because the glossopharyngeal and vagus nerves carry converging afferent fibers, so a base-of-tongue or posterior pharyngeal wall tumor can refer pain to the external auditory canal.

An enlarged, ulcerated tonsil with ipsilateral cervical adenopathy is likely an oropharyngeal head and neck squamous cell carcinoma, and human papillomavirus is the likely etiology in the absence of traditional risk factors like smoking and alcohol in younger patients. A laryngeal ulcer in a smoker is likely squamous cell carcinoma, and persistent hoarseness should always be evaluated by laryngoscopy to ensure no delay in diagnosing a possible cancer.

Nasopharyngeal carcinoma. Epidemiology: endemic to Asia, linked with Epstein-Barr virus reactivation, with risk factors of diet, like salty fish, smoking, and genetics. Manifestations: obstruction with nasal congestion, epistaxis, and headache; mass effect with cranial nerve palsy and otitis media; and spread with a neck mass, cervical lymphadenopathy. Diagnosis: endoscope-guided biopsy. Treatment: radiation therapy and chemotherapy.

Oral Leukoplakia

Oral leukoplakia. Risk factors: tobacco and alcohol use. Clinical features: a painless white mucosal patch that cannot be wiped off. Features that increase cancer risk: a nonhomogeneous gross appearance, large size over four centimeters, and dysplasia on biopsy. Management: biopsy at diagnosis and if the appearance changes, risk factor modification like tobacco cessation, close monitoring, and plus or minus surgical excision.

The differential is oral hairy leukoplakia, which typically presents as multiple white lesions on the lateral tongue with a distinct corrugated appearance that cannot be scraped off, caused by Epstein-Barr virus; because it occurs almost exclusively in patients with significant immunodeficiency, H.I.V testing should be performed, especially with signs of systemic illness. Importantly, oral hairy leukoplakia is not premalignant and can occur in young people, in contrast to oral leukoplakia.

Miscellaneous Pulmonary

This is a grab-bag chapter, but each topic shows up, so let's go one by one.

Chronic Cough

Common etiologies of chronic cough. Upper airway disorders: upper airway cough syndrome, the postnasal drip, and chronic sinusitis. Lower airway and parenchymal disorders: asthma, post-respiratory tract infection, chronic bronchitis, bronchiectasis, lung cancer, and nonasthmatic eosinophilic bronchitis. Other causes: gastroesophageal reflux and ace inhibitors.

For children, the approach to chronic cough, defined as more than four weeks, starts with spirometry. If there is evidence of reversible airway obstruction, give a trial of a short-acting beta agonist plus an inhaled corticosteroid; improvement means treat for asthma. If no reversible obstruction, or no improvement with the trial, get a chest x-ray; an abnormal x-ray means treat the underlying diagnosis, and a normal x-ray means watch and wait. Focal exam findings or specific cough features may guide alternate approaches, like paroxysmal cough in pertussis, suppressible cough in a habit cough, choking or sudden onset for a foreign body, and red flags for tuberculosis or immunodeficiency.

For subacute, three to eight weeks, or chronic, over eight weeks, cough in adults: identify a suspected etiology on history and physical, then evaluate and treat. Stop ace inhibitors; for upper airway cough syndrome, give a first-generation H.1 blocker; for asthma, do P.F.T's; for gerd, an empiric proton pump inhibitor. If there is no improvement after intervention, or there is parenchymal disease, purulent sputum, an immunocompromised host, or no specific etiology, get a chest x-ray. The classic case: a young patient with a chronic nocturnal dry cough and a sensation of liquid dripping into the back of the throat likely has upper-airway cough syndrome, postnasal drip, and should be treated empirically with an oral first-generation H.1 blocker.

Hyperventilation Syndrome

Hyperventilation syndrome is a diagnosis of exclusion characterized by intermittent episodes of hyperventilation without any obvious cardiac or pulmonary etiology. Neurologic symptoms, including paresthesias, headache, lightheadedness, and carpopedal spasms, are often present and may be related to cerebral vasoconstriction or alkalosis-induced hypocalcemia and hypophosphatemia. If the episode does not improve with breathing retraining, a small, not high, dose of a short-acting benzodiazepine like lorazepam is appropriate as second-line therapy. And importantly, breathing into a paper bag was previously recommended to improve hypocarbia by rebreathing C-O _2 , but it can also cause hypoxia and therefore should not be done.

Decompression Sickness

Decompression sickness. Pathophysiology: an abrupt decrease in ambient pressure causes formation of nitrogen gas bubbles within the body. Risk factors: rapid ascent to the surface following a deep dive, obesity because nitrogen is fat-soluble, male sex, and air travel soon after diving, which may further reduce ambient pressure. Presentation: type one is mild illness, musculoskeletal, the bends, plus cutaneous and lymphatic; type two is severe, neurologic, the staggers, and pulmonary, the chokes.

Treatment: intravenous fluids and a hundred percent oxygen, and hyperbaric oxygen therapy as soon as possible. Symptoms usually begin within twelve hours of surfacing. Small air bubbles in the venous bloodstream can lodge in the skin capillaries to cause pruritus or mottling and cyanosis, and in the pulmonary capillaries to cause respiratory distress and localized ischemia with pulmonary edema; a relatively large coalesced volume, around fifty milliliters, can lodge in the right ventricular outflow tract to cause obstructive shock. Air can also pass into the arterial circulation, by overwhelming the pulmonary capillary filter or via a right-to-left shunt like a patent foramen ovale, with small bubbles causing confusion, gait ataxia, and dysarthria, and a small volume, one to two milliliters, causing a localized stroke or myocardial infarction. The emergency treatment is I.V hydration, Trendelenburg positioning, and a hundred percent oxygen, with hyperbaric oxygen being optimal.

High Altitude Sickness

High-altitude illness. Pathogenesis: reduced inspired oxygen at high altitude, over about twenty-five hundred meters or eight thousand feet. Complications: acute mountain sickness, with headache, fatigue, and nausea; high-altitude cerebral edema, where a decreased PaO _2 increases cerebral blood flow, causing lethargy, confusion, and ataxia; and high-altitude pulmonary edema, from uneven hypoxic vasoconstriction, with dyspnea, cough plus or minus hemoptysis, and respiratory distress. Treatment: supplemental oxygen; acetazolamide for acute mountain sickness and dexamethasone for high-altitude cerebral edema; and descent to lower altitude, which is the definitive treatment for all high-altitude illness.

Diffuse Alveolar Hemorrhage

Diffuse alveolar hemorrhage. Etiology and pathogenesis: pulmonary capillaris, like anka vasculitis, lupus, or antiphospholipid antibodies; bland hemorrhage, like mitral stenosis or anticoagulation; and alveolar damage, like viral pneumonitis, A.R.D.S, or drug-induced causes such as cocaine or amiodarone. Clinical presentation and diagnosis: dyspnea, hypoxemia, hemoptysis, which is absent in about fifty percent, and blood-loss anemia; chest x-ray or C.T shows diffuse ground-glass opacities; and bronchoscopy shows progressively bloody return on serial lavage. Management: treat the underlying cause, like rheumatologic or infectious; and supportive care with oxygen and mechanical ventilation, while avoiding anticoagulation. A helpful frame is the differential of diffuse airspace opacification by what fills the alveoli: fluid, either transudative cardiogenic edema or exudative noncardiogenic A.R.D.S; cells, neutrophils as pus in infectious pneumonia, lymphocytes and macrophages in hypersensitivity pneumonitis, eosinophils in acute eosinophilic pneumonia, or malignant cells in carcinomatosis; blood, in diffuse alveolar hemorrhage or aspirated nonalveolar hemorrhage; and others, fat in lipoid pneumonia like from vaping oils, and protein in pulmonary alveolar proteinosis.

Pulmonary Pediatrics

Now a focused pediatric pulmonary block. The thread running through these is the neonatal airway and breathing, and a few classic vignettes that examiners reuse constantly. Let's go.

Choanal Atresia and Charge Syndrome

Choanal atresia is a blockage at the back of the nasal passage. Clinical findings: the unilateral form is most common, with chronic nasal discharge, becoming symptomatic during childhood; the bilateral form causes cyanosis that worsens with feeding and improves with crying, noisy breathing or stertor, and is symptomatic shortly after birth, and it may be associated with Charge syndrome. Diagnosis: an inability to pass a catheter past the nasopharynx, confirmed with a C.T scan or nasal endoscopy. Treatment: an oral airway and surgical repair.

The classic vignette: a generally healthy newborn presents with cyanosis that worsens with feeding and is relieved with crying, despite a normal cardiac and respiratory exam. That is choanal atresia, and failure to pass a catheter through the nose into the oropharynx is suggestive, with C.T confirming the diagnosis. The mechanism to understand is that neonates are obligate nasal breathers, they preferentially breathe through the nose, so complete obstruction in bilateral choanal atresia causes intermittent cyanosis even at rest. When the baby cries, it breathes through the mouth, and the cyanosis improves; when it feeds, the nasal obstruction is unopposed and cyanosis worsens.

Charge syndrome is the association to memorize alongside it. The characteristic features spell the name: Coloboma, meaning missing eye tissue; Heart defects, like tetralogy of Fallot or a ventricular septal defect; Atresia choanae; Retardation of growth and development; Genitourinary anomalies; and Ear abnormalities, like hearing loss. Additional key findings: anosmia, cleft lip or palate, and hypotonia. Diagnosis is clinical, supported by C.H.D.7 gene testing.

Foreign Body Aspiration

Foreign body aspiration. Clinical features: plus or minus a history of a choking event with sudden-onset cough, and symptoms that depend on location; a trachea or main bronchus location gives acute respiratory distress, cyanosis, and stridor for the trachea, or hemoptysis for the bronchial location, while a lower airway location gives chronic or recurrent cough. Examination: a focal, unilateral, monophonic wheeze, and a focal area of diminished breath sounds. X-ray findings: hyperinflation of the affected side, plus or minus mediastinal shift toward the unaffected side, atelectasis if there is complete obstruction, and plus or minus a visible foreign body. Complications: recurrent pneumonia and bronchiectasis. Management: bronchoscopic removal.

The bedside teaching: wheezing and decreased breath sounds on the affected side are characteristic, and hyperresonance to percussion can occur over the hyperexpanded lung. The next step for a child in respiratory distress due to foreign body aspiration is bronchoscopy, and most aspirated foreign bodies end up in the right mainstem bronchus, because it is more vertical. A crucial caveat: a normal radiograph does not rule out foreign body aspiration, because at least thirty percent of radiographs are normal, particularly if a radiolucent foreign body like food is lodged in a small airway; therefore, if clinical suspicion remains high, bronchoscopy is indicated to confirm the diagnosis and remove the object. Sometimes a C.T scan can be used if the x-ray is normal in an asymptomatic child.

Nasal foreign body. Clinical manifestations: an inorganic substance like a toy causes mild pain or discomfort; an organic substance like food causes unilateral, foul-smelling, purulent, bloody discharge; and a button battery causes epistaxis and purulent or black discharge. Treatment: positive pressure expulsion, like forceful exhalation with the unaffected naris occluded, and mechanical extraction. Complications: local irritation, infection like sinusitis, aspiration, and nasal septal perforation, from a button battery or multiple magnets.

Neonatal Respiratory Distress Syndrome

Neonatal respiratory distress syndrome, N.R.D.S. The management flowchart: a neonate with respiratory distress syndrome, first ask about apnea or gasping. If yes, bag-valve-mask ventilation; if there is continued apnea, intubate, give chest compressions, and consider surfactant. If no apnea, or once it resolves, use noninvasive positive airway pressure like C.P.A.P, and consider surfactant. The treatment is nasal C.P.A.P with peep of three to eight centimeters of water, to prevent collapse, and administration of artificial surfactant within two hours postpartum.

The main differential is tran-zee-unt tachypnea of the newborn, the wet lung disease, which occurs in full-term neonates born by cesarean section, whose lungs are still full of fluid, and where therapy should focus on supportive care.

Compare the common causes of neonatal respiratory distress. tran-zee-unt tachypnea of the newborn: pathophysiology is inadequate alveolar fluid clearance at birth, clinical features are tachypnea shortly after birth that resolves by day two of life, and the chest x-ray shows bilateral perihilar linear streaking with fluid within the interlobar fissures. Respiratory distress syndrome: pathophysiology is surfactant deficiency with alveolar collapse and diffuse atelectasis, clinical features are prematurity with severe respiratory distress and cyanosis, and the chest x-ray shows a diffuse ground-glass appearance with low lung volumes and air bronchograms. Persistent pulmonary hypertension: pathophysiology is high pulmonary vascular resistance with a right-to-left shunt, clinical features are tachypnea and severe cyanosis, and the chest x-ray shows clear lungs with decreased pulmonary vascularity. So on imaging, fluid in the fissure is T.T.N, ground-glass with air bronchograms is R.D.S, and clear lungs with reduced vascularity is persistent pulmonary hypertension.

Persistent Pulmonary Hypertension and Polycythemia

Meconium aspiration syndrome occurs in post-term neonates, with the diagnosis established by an unresponsive neonate and green amniotic fluid, and treatment includes emergency intubation. Other causes of neonatal respiratory distress to keep in mind are congenital diaphragmatic hernia, pneumothorax, neonatal pneumonia, sepsis, and lung hypoplasia. The differential for early differential cyanosis is patent ductus arteriosus with R.D.S, and persistent pulmonary hypertension.

For a newborn with respiratory distress and hypoxia secondary to a suspected congenital diaphragmatic hernia, the next step is endotracheal intubation, because the A.B.C's take precedence over diagnostic studies, and a gastric tube should be placed immediately after to decompress the stomach and bowel, which are herniated into the chest.

Here is a great metabolic vignette: an infant two hours after birth has an elevated hematocrit over sixty-five percent, respiratory distress, hypoglycemia, cyanosis, and plethora. This is likely polycythemia of the newborn due to intrauterine hypoxia, with risk factors of smoking, maternal diabetes, and being small or large for gestational age.

Persistent pulmonary hypertension of the newborn. Pathogenesis: abnormal persistence of the elevated fetal pulmonary vascular resistance, with right-to-left shunting across the ductus arteriosus. Risk factors: lung hypoplasia, like in congenital diaphragmatic hernia, meconium aspiration syndrome, and infection like neonatal pneumonia. Examination: a decreased postductal relative to preductal oxygen saturation, respiratory distress and cyanosis, and a prominent S.2. Treatment: oxygenation and ventilation, and inhaled nitric oxide, a pulmonary vasodilator.

Bronchopulmonary Dysplasia

Bronchopulmonary dysplasia. Pathogenesis: a premature arrest of pulmonary development, alveolar hypoplasia with decreased septation, and impaired vasculogenesis. Clinical diagnosis: a premature infant with a continued supplemental oxygen requirement at least twenty-eight days from birth, with some definitions including an oxygen requirement at thirty-six weeks postmenstrual age. Chest x-ray: mild disease shows diffuse hazy infiltrates with low or normal lung volumes, while severe disease shows fibrocystic changes and hyperinflation. Treatment: supportive, with oxygen, nutrition, and fluid restriction or diuretics. Complications: pulmonary artery hypertension, cardiovascular disease like hypertension, and recurrent respiratory infections.

Pediatric Obstructive Sleep Apnea

Pediatric obstructive sleep apnea. Pathophysiology: adenotonsillar hypertrophy, which is the key difference from adults, where obesity dominates. Clinical manifestations: night symptoms of loud snoring, pauses in breathing, gasping, enuresis, and parasomnias like sleepwalking and sleep terrors; and day symptoms of inappropriate naps or falling asleep during school, irritability, inattention, learning and behavioral problems, and mouth breathing with nasal speech.

Complications: poor growth, even failure to thrive, poor school performance, and cardiopulmonary effects like hypertension and structural heart changes. Management: tonsillectomy and adenoidectomy. The mechanism of enuresis is unclear, but it may relate to elevated levels of B-type natriuretic peptide seen with O.S.A, possibly because intermittent obstruction increases cardiac volume and pressure.

Breath-Holding Spells

Breath-holding spells versus seizure, a classic comparison. Cyanotic breath-holding spell: epidemiology is age six months to two years, with increased risk with iron deficiency anemia; the trigger is crying or frustration; clinical features are apnea and cyanosis leading to loss of consciousness, with a rapid return to baseline. Pallid breath-holding spell: triggers are minor trauma or pain or fear; clinical features are bradycardia, apnea, and pallor leading to loss of consciousness, with plus or minus brief, under five minutes, confusion or sleepiness. Seizure: epidemiology is any age, with increased risk with a history of febrile seizure or developmental delay; triggers are often unprovoked, or sleep deprivation; clinical features are loss of consciousness leading to tonic-clonic movements, and prolonged, over five minutes, postictal confusion.

The next step for an infant who experienced a breath-holding spell is reassurance with no further testing, because breath-holding spells are considered normal development with resolution by about five years of age, though screening for associated iron deficiency anemia is recommended because iron-deficient patients typically experience improvement in spell frequency with iron therapy. And a cardiac discriminator: there is no murmur and only very brief cyanosis, in contrast to tetralogy of Fallot, which has a left upper sternal murmur and improvement in cyanosis with squatting.

Sudden Infant Death Syndrome and Drowning

Risk factors for sudden infant death syndrome split into maternal/antenatal and infant. Maternal or antenatal: substance use like cigarettes, alcohol, and recreational drugs; maternal age under twenty; and inconsistent prenatal care. Infant: prematurity or low birth weight; and sleep environment factors, prone or side sleep position, a soft sleep surface, loose bedding, bed sharing, and smoke exposure. Impaired cardiovascular reflexes, like an increased heart rate due to hypercarbia, and diminished arousal responses may account for the elevated risk with smoke exposure. Sudden infant death syndrome is the leading cause of mortality in infants age one month to one year in the United States.

Drowning injuries. Risk factors: children under five and males age fifteen to twenty-five, an inability to swim or inadequate supervision, and concomitant drug or alcohol use. Complications: acute respiratory distress syndrome, cerebral edema, and arrhythmia. Poor prognostic indicators: a submersion time over five minutes, a delay in initiating cardiopulmonary resuscitation, prolonged resuscitative efforts, age over fourteen, and an arterial blood gas pH under seven point one. A patient with purposeful movements demonstrates good functional neurologic ability and indicates a good prognosis, basically showing less hypoxic damage to the brain.

The management of drowning flowchart: acute interventions are to administer rescue breaths first, then chest compressions for cardiac arrest, remove wet clothing to improve hypothermia, and transport to the emergency department. In the emergency department, a symptomatic patient gets maintenance of oxygenation and ventilation, with continuous cardiopulmonary monitoring and supportive care like supplemental oxygen, noninvasive ventilation, or intubation, and evaluation with chest x-ray, E.C.G, A.B.G, C.B.C, electrolytes, and a drug screen in adolescents and adults; an asymptomatic patient is observed for at least eight hours with continuous cardiopulmonary monitoring, monitored for signs of A.R.D.S like dyspnea and wheeze, with a chest x-ray at the end of observation to assess for pulmonary edema and plus or minus an A.B.G, C.B.C, electrolytes, and drug screen. The reason for observation is that even if the fluid is coughed out quickly and normal ventilation is restored, the fluid may already have caused damage capable of producing delayed pulmonary complications, including direct tissue injury from chemicals or contaminants leading to inflammation, washout of alveolar surfactant leading to alveolar collapse, and disruption of the osmotic gradient of the alveolar-capillary membrane leading to increased fluid permeability; together these progressively impair oxygen exchange and cause atelectasis, decreased lung compliance, and non-cardiogenic pulmonary edema.

Pulmonary Surgery and Chest Trauma

We finish with the surgical and trauma side of the chest. The big themes are preventing postoperative pulmonary complications and managing chest trauma, where a few hard numbers and decision rules carry real weight.

Perioperative Pulmonary Care

In all patients anticipating elective surgery, immediate smoking cessation is recommended, because those who quit smoking more than four to eight weeks prior to surgery substantially decrease their postoperative pulmonary risk. Lesser durations of preoperative cessation do not reduce the risk, likely because the airway inflammation and increased bronchial mucus production induced by smoking require some time to improve.

Postoperative pulmonary complications. The complications themselves are atelectasis, bronchospasm, pneumonia, and a prolonged ventilator requirement. Risk factors: age over fifty, active smoking, underlying heart failure or obstructive lung disease, and emergency surgery or a surgery duration over three hours.

Perioperative prevention: smoking cessation more than four to eight weeks prior to surgery, symptomatic control of underlying lung disease, and pain control, deep-breathing exercises, and incentive spirometry. The patients at greatest risk for postoperative pulmonary complications are those with C.O.P.D, cigarette smoking, sleep apnea, and heart failure; prior to an elective procedure, these conditions should be optimized, typically including smoking cessation ideally more than four weeks prior, and treatment of any heart failure or C.O.P.D exacerbation.

On pain: uncontrolled postoperative pain often presents with patient discomfort, tachycardia, tachypnea, hypertension, and respiratory splinting, particularly for thoracic and upper abdominal incisions. Adequate pain control following a surgical procedure is necessary to decrease the risk of postoperative complications such as pneumonia, and patient-controlled analgesia is a frequently used option to provide opioid-based pain relief after surgery.

Postoperative Atelectasis and Hypoxemia

Common causes of postoperative hypoxemia, by timing after surgery. Airway obstruction or edema: immediate, with stridor commonly, often due to endotracheal intubation or pharyngeal muscle laxity. Residual anesthetic effect: immediate, from anesthetic agents, benzodiazepines, and opiates, with a diminished respiratory drive, decreased rate or tidal volume.

Bronchospasm: typically early, with wheezing. Pneumonia: one to five days, with fever, an elevated white count, purulent secretions, and an infiltrate. Atelectasis: two to five days, after thoracoabdominal surgeries, with splinting, reduced cough, and retained secretions. Pulmonary embolism, thromboembolic or fat: uncommon before three days, with chest pain, tachycardia, and little improvement on supplemental oxygen.

Postoperative atelectasis commonly occurs due to shallow breathing and a weak cough secondary to pain, typically manifesting on postoperative day two or three. The shallow breathing causes hypoxia with resultant tachypnea and low C-O _2 , a respiratory alkalosis. Arterial blood gas typically reveals an increased alveolar-arterial gradient due to intrapulmonary shunting, and the chest x-ray characteristically shows linear opacifications in the bilateral lung bases, sometimes with a shift of structures toward the opacification if the atelectasis is large. The breathing instrument useful for preventing postoperative atelectasis is the incentive spirometer, which teaches patients to take slow, deep breaths that open up the airways and prevent collapse.

Once atelectasis develops, it can be treated with continuous positive airway pressure, C.P.A.P, to help open collapsed alveoli. For patients with minimal respiratory secretions, C.P.A.P is often effective; however, those with more copious secretions, like a patient with a cough productive of white sputum, are most appropriately managed with aggressive pulmonary hygiene, including chest physiotherapy and suctioning, rather than C.P.A.P. C.P.A.P may stent the airways open, but if that is not sufficient to promote ventilation, escalation to B.i.P.A.P or invasive positive pressure ventilation may be required. And incentive spirometry also helps prevent postoperative pneumonia.

Flail Chest

Flail chest. Pathophysiology: three or more contiguous ribs fractured in at least two locations, creating a free-floating flail segment. Findings: paradoxical chest wall motion with respiration, chest pain, tachypnea, rapid shallow breaths, and a chest x-ray showing rib fractures plus or minus contusion or hemothorax. Management: pain control and supplemental oxygen, and positive pressure ventilation, plus or minus a chest tube, if there is respiratory failure. The flail segment moves inward on inspiration, the paradoxical motion, due to the negative intrathoracic pressure pulling the unsupported segment in while the rest of the chest expands out.

Rib Fractures and Pulmonary Contusion

The most essential part of management for an uncomplicated rib fracture, with no hypotension or pneumothorax, is pain control, which is essential to maintain deep breathing and an adequate cough, helping prevent atelectasis and pneumonia.

The extreme blunt force required to create a flail chest typically injures the underlying lung, resulting in a pulmonary contusion, seen on x-ray as infiltrates underlying the patient's rib fractures, which decreases oxygen diffusion due to alveolar hemorrhage and edema. As a result, patients must breathe harder to maintain oxygenation, and the combination of increased work of breathing and decreased oxygenation causes many patients to fatigue and develop respiratory failure, requiring mechanical ventilation.

Pulmonary contusion specifically. Clinical features: present within twenty-four hours after blunt thoracic trauma, with tachypnea, tachycardia, and hypoxia. Diagnosis: rales or decreased breath sounds, and a C.T scan, the most sensitive, or chest x-ray, showing a patchy alveolar infiltrate not restricted by anatomical borders, an irregular, nonlobular infiltrate. Management: pain control, pulmonary hygiene like incentive spirometry and chest physiotherapy, and supplemental oxygen and ventilatory support.

Blunt Chest Trauma and Hemothorax

Blunt chest trauma is sorted by hemodynamic status. A hemodynamically unstable patient undergoes resuscitation and evaluation with an extended focused assessment with sonography for trauma, the e.F.A.S.T, a chest x-ray, an E.C.G, and plus or minus a stabilizing intervention like a chest tube if indicated; then you reassess whether hemodynamic stability is achieved or maintained, and if not, the patient goes to the operating room for thoracotomy. A hemodynamically stable patient is screened for a high-risk mechanism or serious injury on examination; if present, they get the same resuscitation and evaluation pathway; if not, you look for abnormal findings on evaluation, chest x-ray, or E.C.G; if those are abnormal, additional tests like a C.T of the chest, and if normal, possible discharge or observation.

Hemothorax. The underlying cause of hemorrhagic shock in a patient with decreased breath sounds, tracheal deviation, and dullness to percussion is a hemothorax, and each hemithorax is capable of holding up to fifty percent of the circulating blood volume, which is why this causes shock. The treatment of a hemothorax is, first, chest tube insertion, a thoracostomy; and second, thoracotomy, indicated if there is more than fifteen hundred milliliters of initial output, or more than two hundred milliliters per hour for more than two hours, or a continuous need for transfusion to maintain hemodynamic stability. A hemothorax, however small, must always be drained, because blood left in the pleural cavity will clot if not evacuated, resulting in a trapped lung or an empyema. Tube thoracostomy, the chest tube insertion, involves placing a hollow plastic tube between the fourth or fifth intercostal space at the midaxillary line into the chest to decompress a hemothorax or pneumothorax. Hemothorax may result from injuries to large structures like the ay-or-tuh or hilar vessels, or small intrathoracic structures like the intercostal blood vessels and lung parenchyma.

Life-Threatening Hemoptysis and Tracheobronchial Injury

A reminder on life-threatening hemoptysis, with a jeopardized airway, severe hypoxemia, or hemodynamic instability: it generally occurs with bleeding rates over one hundred milliliters per hour, and it is managed by securing the airway, placing the patient's bleeding bad lung down if lateralization is known to prevent spillover into the good lung, and obtaining urgent hemostatic control via bronchoscopy, embolization, or surgery.

Tracheobronchial injury, the last topic. Clinical features: dyspnea, hoarseness, dysphonia, and bloody tracheal secretions; subcutaneous emphysema; a treatment-resistant pneumothorax, importantly not a tension pneumothorax; and pneumomediastinum, air in the mediastinum, which may produce Hamman's sign. Diagnostics: chest x-ray showing air in the surrounding soft tissue, and bronchoscopy to visualize the lesion. To distinguish it from a tension pneumothorax, tracheobronchial injury usually does not feature midline shift and distended neck veins.

Complications: chylothorax, chylopericardium, and chylomediastinum. Treatment: mostly surgical repair.

Here is how it presents and resolves on the exam: a persistent pneumothorax with a significant air leak following chest tube placement in a patient with blunt chest trauma suggests tracheobronchial rupture, and other findings include pneumomediastinum and subcutaneous emphysema. The definitive diagnosis is by bronchoscopy, and the treatment is surgical repair. So if the chest tube is in but the lung will not stay up and air keeps leaking, think a torn airway, confirm with bronchoscopy, and fix it surgically.

And that brings us all the way through the chest, from the first breath of physiology to the operating room. If you have followed the logic at each step, the ventilation-perfusion spectrum, the obstructive versus restrictive split, the way infections and effusions and emboli each leave their own fingerprint on the exam and the imaging, then you are not memorizing a list, you are reasoning through the lung. That is exactly how you want to walk into the exam, and into the wards.

You have reached the end of the document.